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ABSTRACT
Translocation of membrane proteins from the point of synthesis to their integration in the 
membrane is critical to the function of the cell. Tail-anchored (TA) proteins are an important 
class of membrane proteins with a single transmembrane domain (TMD) close to the 
carboxyl-terminus. They are defined topologically by having their amino-terminus in the 
cytosol and their carboxyl-terminus on the exterior side of the membrane. Since the TMD is 
sequestered by the ribosome during translation, co-translational translocation of TA proteins 
by the SRP-dependent pathway is not possible. The Guided Entry of Tail-anchored proteins 
(GET) pathway post-translationally targets TA proteins to the endoplasmic reticulum (ER) 
membrane. The conserved nucleotide hydrolase Get3 is the central protein in the pathway that 
specifically binds the TMD of TA proteins to chaperone them from a sorting complex of 
Get4, Get5, Sgt2 and other chaperones to an ER membrane receptor formed by Get1 and 
Get2. We have created a model for the mechanism of Get3 TA protein binding coupled to 
nucleotide state using X-ray crystallography, structural modeling and mutagenesis experiments. 
We then demonstrate expression, purification and crystallization of complexes of Get3 with 
TA proteins for structural studies. Finally, we present a crystal structure of a tetrameric 
archaeal Get3 homologue that forms a central hydrophobic chamber and is capable of binding 
TA proteins. Using small-angle X-ray scattering, the structure is comparable to a tetrameric 
fungal Get3 complex with TA protein, which is capable of TA protein membrane integration 
in vitro. This suggests a model in which a tetramer of Get3 binds TA proteins for delivery to 
the membrane.
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INTRODUCTION
Protein localization is a process essential to the complexity of life. One of the most 
fundamental types of localization is integration of proteins into a membrane. Integral 
membrane proteins perform an essential and diverse set of functions in the cell including 
transport, signaling and metabolism in all three domains of life. Understanding membrane 
protein localization in a broader context is fundamental to biology.
By definition, integral membrane proteins must reside in a membrane and generally do so by 
one or more hydrophobic regions that are thermodynamically stable in a lipid bilayer. For 
localization this common feature must be considered in how integral membrane proteins get 
from the point of synthesis by the ribosome to their destination in a membrane through the 
polar environment of the cytosol. The architecture of integral membrane proteins is as varied 
as their function with different arrangements of transmembrane segments as well as structures 
of soluble domains on either side of the membrane. Accommodations must be made for the 
range of membrane protein configurations during their localization and integration. 
Membrane localization becomes further complicated in eukaryotic organisms where there are 
distinct membranes from different organelles in addition to the plasma membrane.
The signal recognition particle (SRP) pathway is a universally conserved mechanism for 
targeting not only proteins integrated into the membrane but also secreted proteins (reviewed 
Shan and Walter, 2005). Proteins targeted by the SRP pathway contain an amino-terminal (N-
terminal) hydrophobic signal sequence, and as a nascent protein is synthesized by the ribosome 
the SRP binds the sequence. The complex of SRP and the ribosome nascent chain (RNC) 
binds to the SRP receptor (SR), at which point the RNC is delivered to the Sec translocon for 
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integration. Many integral membrane proteins are localized by the SRP pathway, but there are 
important exceptions.
TA Protein Translocation
In 1993 a review by Kutay et al. recognized that a class of proteins with a transmembrane 
domain (TMD) at their extreme carboxyl-terminus (C-terminus) would be inaccessible to the 
SRP pathway. These tail-anchored (TA) proteins lack an N-terminal signal sequence so only 
the TMD could act as a signal anchor. The proximity of the signal anchor to the C-terminus 
causes it to be occluded by the ribosome during synthesis and, therefore, unavailable to the 
SRP during translation. Thus TA proteins must be targeted post-translationally to the 
membrane for integration. TA proteins are an important class of proteins comprising 2–3% of 
open reading frames in humans and 1% in yeast and carry out a wide array of functions 
including vesicle fusion, apoptosis regulation and enzymatic activity (Beilharz et al., 2003; 
Kalbfleisch et al., 2007).
The model system for TA protein translocation has been the membrane bound form of the 
heme-binding electron transfer protein cytochrome b5. The first mechanism shown for 
membrane integration of a TA protein was the spontaneous insertion of cytochrome b5 in 
vitro into liposomes and other membranes (Dailey and Strittmatter, 1978; Takagaki et al., 
1983). In contrast to most TA proteins, the TA of cytochrome b5 is only moderately 
hydrophobic and cytochrome b5 can exist in a soluble form (Brambillasca et al., 2006). When it 
was shown that the tail-anchored synaptobrevin, unlike cytochrome b5, requires ATP and a 
proteinaceous factor at the membrane for insertion in vitro, it became clear that there are other 
mechanisms for TA insertion (Kutay et al., 1995). The behavior of cytochrome b5 and similar 
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TA proteins is likely not the primary route for TA protein insertion (Mandon and Gilmore, 
2007).
Work on finding a general mechanism for TA protein translocation continued with a number 
of important criteria for their targeting being defined. SRP was shown to not be necessary for 
proper targeting (Kutay et al., 1995). Furthermore, TA protein targeting to the ER was shown 
to be independent of the Sec components in both their co- and post-translational translocating 
forms (Kutay et al., 1995; Steel et al., 2002; Yabal et al., 2003) although the exact nature of this 
property continued to be debated (Abell et al., 2004). More than a decade after Kutay et al. 
published their review about TA proteins, the process of  their biogenesis was still enigmatic.
A Targeting Factor for TA Proteins
In 2007 the first component of the pathway currently considered to be the mechanism of TA 
protein translocation was discovered. Stefanovic and Hegde (2007) and Favaloro et al. (2008) 
demonstrated that a 40 kDa putative ATPase specifically bound TA-proteins and facilitated 
their translocation in an energy and membrane-associated protein dependent manner, meeting 
the criteria found for insertion of synaptobrevin. Stefanovic and Hegde (2007) named the 
complex associated with TA proteins the Transmembrane domain Recognition Complex 
(TRC) and the targeting factor TRC40.
A large body of work on the gene encoding TRC40 preceded its discovery as the TA protein 
targeting factor. The first identified gene encoding a TRC40 homolog was annotated in 1992 
as a homolog of ArsA, a bacterial ATPase arsentite transport protein, as part of the 
Caenorhabditis elegans genome sequencing project (Sulston et al., 1992). Kaur and Rosen (1992) 
noted this as the only known eukaryotic homolog of ArsA, and Koonin (1993) recognized the 
C. elegans gene was different from the bacterial Escherichia coli and Mycobacterium leprae ArsA 
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genes in that it encoded only one, not two putative ATPase domains. Another eukaryotic 
homolog of ArsA was identified in Saccharomyces cerevisiae as part of the sequencing of 
chromosome IV, revealing close homology to the C. elegans sequence (Boskovic et al., 1996). 
Kurdi-Haidar et al. (1996) isolated the Homo sapiens homolog of ArsA and showed it was 
universally expressed in different tissues.
In S. cerevisiae deletion of the open reading frame YDL100c, encoding the ArsA homolog, 
showed a growth defect phenotype in the presence of metals (zinc, copper and cobalt) and 
elevated temperatures (Zúñiga et al., 1999). Zúñiga et al. (1999) suggested YDL100c was 
involved in export of toxic compounds, similar to the function of E. coli ArsA, and was 
upregulated as part of the heat shock response. Shen et al. (2003) added to the idea YDL100c 
was involved in metal and heat tolerance including arsenite, chromium and vanadate and 
annotated YDL100c as ARR4.
Schuldiner et al. (2005) looked at S. cerevisiae epistatic genetic interactions through growth 
defects in double knockouts of different genes and focused on Arr4 as an example for 
identification of components in novel pathways. The study implicated Arr4 in a Golgi to ER 
retrieval (GET) pathway and changed the name Arr4 to Get3. They also identified two other 
components of the pathway that together formed a receptor in the ER membrane, which they 
called Get1 and Get2. A subsequent study showed get3 mutants suppressed a phenotype of a 
temperature sensitive npl4 mutant, a gene involved in the ER-associated degradation of 
proteins by the ubiquitin-proteasome system, and Δget3 suppresses Δget1 and Δget2 
phenotypes (Auld et al.,  2006). Furthermore, Get3 was shown to associate with the ER 
membrane through Get1 and Get2 (Auld et al., 2006). Get3 was demonstrated to bind a 
chloride-transport protein Gef1 and could regulate copper levels, a biochemical link to the 
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metal related growth defect phenotypes for Δget3 (Metz et al., 2006). Get3 was also shown to 
function as a guanine-triphosphate (GTP) exchange factor (GEF) like G protein-coupled 
receptors, directly binding a G protein Gpa1 in a nucleotide dependent manner (Lee and 
Dolhman, 2008). 
Studies from other organisms examined metal tolerance as well as additional roles for the 
eukaryotic ArsA homolog. The homolog was shown to be essential in Mus musculus with a 
knockout being lethal at the embryonic stage of development (Mukhopadhyaya et al., 2006). 
Work on the C. elegans homolog by Tseng et al. (2007) focused on the idea that the homolog 
was involved in metal tolerance, similar to bacterial ArsA and previous studies of the S. 
cerevisiae homolog, by purifying the C. elegans homolog and showing in vitro ATPase activity was 
stimulated in the presence of arsenite. The C. elegans knockout of the ArsA homolog reversibly 
went into dauer, arresting development in the L1 stage due to a defect in regulation of insulin 
secretion (Kao et al., 2007). Human melanoma cells were sensitive to arsenite and cisplatinin, a 
cancer therapeutic, when Get3 was downregulated by siRNA (Hemmingsson et al., 2008).
When Stefanovic and Hegde (2007) and Favaloro et al. (2008) identified the mammalian ArsA 
homolog (TRC40) to be a factor for TA protein targeting, Schuldiner et al. (2008) revisited 
their previous work with the S. cerevisiae homolog (Get3) (Schuldiner et al., 2005). They 
confirmed the GET pathway as a TA protein targeting pathway and modified the basis of the 
acronym to Guided Entry of Tail-anchored proteins. The proteins Get1/2 were then shown 
to form the membrane protein receptor for Get3. In Δget1/2 strains of S. cerevisiae, cytosolic 
aggregates of TA proteins bound to Get3 and failed to localize TA proteins to the ER 
membrane in vivo. Insertion of TA proteins by Get3 into microsomes was also dependent on 
Get1/2 in vitro. Further studies by Jonikas et al. (2009) in S. cerevisiae showed strong 
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interactions between Get3 and the proteins Yor164 and Mdy2, which were then named Get4 
and Get5. The Δget4 and Δget5 phenotypes were masked by Δget3, and Δget4 and Δget5 strains 
mislocalized ER destine TA proteins to mitochondria. Extracts used for in vitro translocation 
assays from Δget5 strains failed to insert TA proteins into microsomes. Get3 was shown to 
interact with Get4/5 by immunoprecipitation. This evidence taken together suggested Get4/5 
worked upstream of Get3 with Get3 at the center of a pathway chaperoning TA proteins 
from Get4/5 to the membrane receptor Get1/2. The many other functions attributed to 
TRC40/Get3 have yet to be explained as either directly or indirectly related to TA protein 
targeting or as alternative functions, and Get3 is now generally accepted as a targeting factor 
for TA proteins to the ER.
Get3 as a Nucleotide Hydrolase
The close sequence homology between Get3 and ArsA is confined mostly to their nucleotide 
hydrolase domains (NHD) even though they were originally annotated as homologous and 
having similar functions. Proteins that bind and hydrolyze nucleoside-triphosphate (NTP) are 
ubiquitous and involved in a multitude of processes essential to life. NTP binding and 
hydrolysis is employed by a wide range of proteins with a variety of localizations, biological 
functions and molecular mechanisms. NTPases include chaperones and targeting factors with 
similar function to Get3 such as heat shock proteins and the SRP, respectively. The energy of 
NTP hydrolysis is often used to drive conformational changes that regulate interactions with 
other proteins, and the structure of NTPases have revealed how their molecular mechanism is 
related their function. Structural information about Get3 could serve as the basis for 
understanding how nucleotide hydrolysis is coupled to binding TA proteins and the process by 
which they are targeted for membrane integrProfessoration at the ER.
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NTPases can be classified by their structure and divided into a number of distinct folds 
including the P-loop (phosphate-binding loop) containing NTPase fold (Saraste et al., 1990). 
There are a number of distinct sequence and structural groups within P-loop containing 
NTPases, and the NHD of ArsA, the closest sequence homolog to Get3, falls within the 
superclass of P-loop containing GTPases (Bourne et al., 1991; Koonin, 1993). The P-loop 
containing GTPase superclass also includes ATPases, contrary to their name, but will be still be 
referred to as P-loop GTPases to avoid overlapping nomenclature with the larger group of P-
loop NTPases.
The structure of the NHD of P-loop containing NTPases is a mix of mostly alternating α-
helices and β-strands with conserved motifs residing in the loops that connect them. The α/β 
fold, which describes the mixed secondary structure, forms a tertiary structure that sandwiches 
a seven strand β-sheet between two groups of α-helices exposing the connecting loops on the 
edges. Motifs within the loops are important for binding and hydrolysis of nucleotide as well 
as sensing nucleotide state and are located on one edge of the β-sheet. These conserved 
motifs define the P-loop GTPase superclass from other P-loop NTPases.
Motifs are illustrated in Figure 1 and include the P-loop, also called a Walker A motif or G1 
region, with the consensus sequence GxxxxGK(S/T) (x for any amino acid) that forms a loop 
after strand 1 (β1). This motif interacts with the phosphates of a bound nucleotide (Walker et 
al., 1982). In P-loop GTPases the switch II region, also called a Walker B motif or G3 region, 
following β4 has the sequence hhhhDxxG (h for hydrophobic amino acids) and is involved in 
magnesium ion coordination and binding the γ-phosphate of the nucleotide (Walker et al., 
1982; Bourne et al., 1991). Conserved features with less consensus in terms of sequence 
include the switch I or G2 region after β2 that coordinates a magnesium ion bound to the β- 
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and γ-phosphates of the nucleotide. Also, a nucleotide specificity motif (N/T)KxD (G4 
region) following β6 that is conserved for GTPases (Bourne et al., 1991) but with notable 
exceptions including ATPases like Get3. Main chain interactions from the A-loop (as named 
in ATPases) or G5 region after β7 interact with the nucleotide but are not strictly conserved 
as a motif.
P-loop GTPases can then be divided into two major classes based on their sequence and 
structure: the TRAFAC (translation factor) class and the SIMIBI (signal recognition particle, 
MinD, BioD) class (Leipe et al., 2002). The TRAFAC class includes Ras, EF-Tu and ATPases 
kinesin and myosin and is defined by having β2 on the outermost edge of the core β-sheet. A 
conserved threonine or serine in the switch I region is followed by an anti-parallel β3. Get3 
falls within the SIMIBI class of GTPases, which have parallel β2 and β3 with their positions 
swapped compared to TRAFAC GTPases. The SIMIBI class is divided into three 
classifications reflected in the acronym: SRP family, MinD superfamily and BioD family.
Leipe et al. (2002) provide an evolutionary classification of P-loop GTPases based on 
sequence, which can be used to further define the most appropriate proteins to relate Get3 
with molecular mechanism. The MinD superfamily has only the aspartate of (N/T)KxD 
guanine nucleotide specificity motif conserved and is divided into the MinD/Mrp and Etk 
families. The MinD/Mrp family has a characteristic P-loop/Walker A motif named the 
“deviant” Walker A motif, GKGGhGK(S/T), with a lysine in the second position followed by 
two glycines. The MinD/Mrp family is finally divided into subfamilies of essentially 
homologous proteins. Get3 is technically part of the ArsA subfamily, but the NifH subfamily 
and other MinD/Mrp family members are suitable for speculating on how Get3 functions as 
a nucleotide hydrolase.
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The Structure and Mechanism of  Related P-loop GTPases 
There have been a number of structural and functional studies of members of the MinD/
Mrp family. The nitrogenase iron protein (Fe-protein) was the first family member to be 
structurally characterized (Georgiadis et al., 1992). The Fe-protein fixes nitrogen through 
conversion of nitrogen gas to ammonia in an ATP hydrolysis dependent electron transfer to a 
partner molybdenum-iron protein (MoFe-protein). Transfer by the complex occurs through an 
iron-sulfur cluster in the Fe-protein to the P-cluster and then iron-molybdenum cofactor in the 
MoFe-protein complex (Howard and Rees, 1994). The structures of the nitrogenase complex 
between the Fe- and MoFe-proteins in different nucleotide states illustrates the mechanism of 
the Fe-protein during nucleotide binding and hydrolysis (Schindelin et al., 1997; Tezcan et al., 
2005). ATP binding by the Fe-protein is coupled to the formation of the nitrogenase complex 
by conformational changes that occur when binding the MoFe-protein. Rotation between the 
two subunits of the Fe-protein form a compact overall structure (Figure 2A & B), presenting a 
specific binding interface for the MoFe-protein (Schindelin et al., 1997). Similar to the Fe-
protein, Get3 interactions with other proteins including TA proteins, Get1/2 and Get4/5 
could be regulated by different nucleotide dependent conformations. The key features and 
conformational changes in the structures of the Fe-protein serve as a basis for examination of 
Get3 and the MinD/Mrp family as a whole.
Structural studies of the arsenite transport protein ArsA (Zhou et al., 2000; 2001), the closest 
sequence homolog to Get3, followed the initial structural characterization of the Fe-protein. 
ArsA binds to an integral membrane protein channel, ArsB, to form an arsenite export 
mechanism with ArsA as the catalytic subunit. The hypothesis that the tandem repeat of 
ATPase domains in ArsA could serve to form a pseudo-dimer, fulfilling the 
homodimerization requirement for the Fe-protein, (Li and Rosen, 2000) was confirmed by the 
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structure. Arsenite or antimonite is coordinated by conserved histidines and cysteines in the 
regions connected to the NHD (Zhou et al., 2000). Structures of ArsA in different nucleotide 
states show significantly less conformational change than the Fe-protein, with minor changes 
in the switch I and II, P-loop and A-loop regions (Figure 3) (Zhou et al., 2001). This suggests 
the mechanism of ArsA requires only small alterations in the coordination geometry of 
arsenite to drive arsenite transport, or the constraints of packing in the crystal used for 
structure determination preclude large conformational changes (Zhou et al., 2001; Lutkenhaus 
and Sundaramoorthy, 2003). Additionally, binding of ATP, the ATP analog AMPPNP or the 
transition state analog ADP·AlF3 only takes place in one of the two NHDs (Zhou et al., 2001). 
The model for the mechanism of arsenite transport based on the structures was a 
reciprocating pump driven by ArsA in one NHD at a time (Zhou et al., 2001). This contrasted 
to the binding, simultaneous hydrolysis and release mechanism of nitrogenase. As the closest 
sequence homolog to Get3, the structure and mechanism of ArsA is logical for comparison 
to Get3.
MinD was the next family member structurally characterized and is part of a regulatory system 
for septum formation in cell division (Cordell and Löwe, 2001; Hayashi et al., 2001; Sakai et al., 
2001). Homodimeric MinD bound to ATP associates with the membrane through a C-
terminal amphipathic helix. MinC binds to MinD to inhibit the cell division protein FtsZ but is 
displaced by MinE, resulting in ATP hydrolysis and dissociation from the membrane by MinD 
(Lutkenhaus, 2007). MinD exists as a monomer in solution, and structures determined in a 
variety of nucleotide states were all monomeric (Cordell and Löwe, 2001; Hayashi et al., 2001; 
Sakai et al., 2001). The mechanism of MinD through ATP hydrolysis was framed in the 
context of the homodimeric Fe-protein by structural alignment of the monomers to the Fe-
protein (Lutkenhaus and Sundaramoorthy, 2003). There is little difference between the ATP 
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analog AMPPCP and ADP bound states suggesting the AMPPCP bound structure does not 
completely represent the ATP bound state (Figure 4) (Lutkenhaus and Sundaramoorthy, 
2003). From these structures it is difficult to determine what rearrangements take place during 
nucleotide hydrolysis that regulate membrane binding and association with MinC and MinE. 
Nevertheless, nucleotide binding features and association with the membrane are topics 
relevant to Get3.
Structures of another family member, Soj, were determined in apo, ADP and ATP bound 
states (Leonard et al., 2005). The protein Soj has many parallels in function and structure to 
MinD including spatial oscillations and polymerization in the cell and close sequence 
homology, except for the membrane associating C-terminal amphipathic helix of MinD 
(Lutkenhaus and Sundaramoorthy, 2003). Soj functions as part of a bacterial chromosome 
partitioning system forming filaments on DNA as a homodimer bound to ATP (Ebersbach 
and Gerdes, 2005; Ghosh et al., 2006). Hydrolysis and release from DNA is stimulated by the 
N-terminus of Spo0J, a protein that binds to a specific site in the chromosome. As for MinD, 
structures of Soj in apo and ADP bound forms were monomeric, but a dimeric ATP bound 
structure was solved using a hydrolysis deficient mutant (Leonard et al., 2005).
The MinD/Mrp family member ParA is also part of a plasmid partitioning system and is very 
similar to Soj with a partner protein ParB analogous to Spo0J (Ebersbach and Gerdes, 2005; 
Ghosh et al., 2006). Structures of ParA (type Ib) in an ATPγS bound state (Pratto et al., 2008) 
as well as apo and ADP bound states of a ParA with a specific DNA binding winged helix-
turn-helix motif (type Ia) (Dunham et al., 2009) have been determined. Unlike Soj, ParA was 
dimeric in solution even in apo or ADP bound states. Despite Soj and MinD having similar 
structure to the monomeric subunit of ParA, the ParA ATPγS bound dimer structure differs 
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from the hydrolysis inactive dimer structure of Soj with a more open conformation exposing 
the nucleotides (Pratto et al., 2008). The ParA apo and ADP structures adopt a range of dimer 
conformations in different crystal forms mediated through an N-terminal α-helical extension 
(Figure 6) (Dunham et al., 2009). Although closely related to Soj, the structures of ParA show 
significant differences in oligomerization related to nucleotide states and in conformation 
between the subunits of  the dimer.
Homodimerization at the NHDs seems to be a prerequisite for ATP hydrolysis in deviant 
Walker A motif containing proteins, including Get3. The intersubunit interaction by the first 
conserved lysine in the motif to the nucleotide phosphates is thought to stabilize negative 
charge in the transition state and be necessary for nucleotide hydrolysis (Figure 2A) (Koonin, 
1993; Schindelin et al., 1997). Fe-protein dimerization is covalently linked by the iron-sulfur 
cluster, but additional hydrophobic and hydrogen-bonding interactions between the subunits 
are sufficient to maintain the dimeric state (Howard et al., 1989; Georgiadis et al., 1992). 
Covalent dimerization is also present in ArsA, and similar to the Fe-protein additional 
interactions are present (Zhou et al., 2000). The ParA dimer lacks the covalent linkage of the 
Fe-protein and ArsA and is stabilized by interactions through hydrophobic surfaces and 
hydrogen-bonding between several residues (Pratto et al., 2008; Dunham et al., 2009). MinD 
and Soj function with a different mechanism where they go from a monomeric to a dimeric 
state upon binding ATP (Hu and Lutkenhaus, 2003; Leonard et al., 2005). Overall, Mrp/MinD 
family members related to Get3 function as homodimers, and there are several models for the 
nature of  dimerization depending on the protein.
The deviant Walker A motif not only binds nucleotide through α and β-phosphates but is 
involved in catalysis (Koonin, 1993). The conformation of the P-loop when nucleotide bound 
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is generally invariant, and the Fe-protein, ArsA and MinD structures show little change in P-
loop position between nucleotide states (panels C & D from Figures 2 & 3, Figure 4) 
(Schlessman et al., 1998; Zhou et al., 2001). There are differences in P-loop conformations 
between apo and nucleotide bound states as seen in Soj (Figure 5), and ParA structures where 
extended or disordered forms of the P-loop move to form close interactions with the α and 
β-phosphates of ADP (Figure 6C & D) (Leonard et al., 2005; Pratto et al., 2008; Dunham et 
al., 2009). In the structure of the Fe-protein bound with the transition state analog 
ADP·AlF4-, the first conserved lysine of the motif interacts with β  and γ-phosphates of the 
bound nucleotide in the opposing subunit, an interaction not seen in the ADP bound structure 
(Figure 7A) (Schindelin et al., 1997). The Fe-protein structures are the standard for examining 
MinD/Mrp family members. Comparison of dimeric ATP bound Soj to the transition state of 
the Fe-protein also showed the deviant Walker A lysines in position to interact with the α and 
β-phosphates of the ATP molecule (Figure 7B) (Leonard et al., 2005). The interaction is not 
present in ParA dimer structures (Pratto et al., 2008; Dunham et al., 2009), but mutation of the 
lysine to alanine shows reduced ATPase activity (Pratto et al., 2008). Biochemical analysis of 
MinD has also shown the deviant Walker lysine essential for catalysis (de Boer et al., 1991), but 
due to the monomeric states of the structures the interaction is not seen (Cordell and Löwe, 
2001; Hayashi et al., 2001; Sakai et al., 2001). The structures of ArsA with ADP·AlF3, ATP or 
AMPPNP bound lack this interaction (Zhou et al., 2001). P-loop interactions, especially the 
deviant Walker A lysine, are crucial for interpreting the structures of MinD/Mrp family 
members.
The switch II region senses the γ-phosphate of bound ATP to drive conformational changes 
from the apo or ADP bound state and interacts with the nucleotide phosphates and 
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magnesium ion. In structures of the Fe-protein, the differences in switch II interactions 
between the apo and nucleotide bound forms result in conformational changes to proximal 
parts of the protein that govern function (Figure 2 & 8A). The rearrangement of the switch II 
region serves as a mechanism for transmitting nucleotide state and positions the iron-sulfur 
cluster closer to the MoFe-protein for electron transfer (Schindelin et al., 1997; Schlessman et 
al., 1998). Additionally, an aspartate from the opposite switch II region could position a water 
for a catalytic attack on the nucleotide. In ArsA, arsenite or antimonite is coordinated by 
histidines several residues C-terminal to the switch II region allowing for direct movement of 
these residues (Zhou et al., 2000). There is little difference in the structures of ArsA in 
different nucleotide states so switch II movements are not seen (Figure 3 & 8B) (Zhou et al., 
2001; Lutkenhaus and Sundaramoorthy, 2003). The ADP and ATP bound structures of MinD 
also show little conformational change suggesting either the difference in nucleotide is not 
related to the function of the protein or there is crystallographic constraint of the 
conformation (Hayashi et al., 2001). Comparison of the Soj ADP and ATP structures shows 
little difference in switch II as well, and with ATP bound the P-loop is shifted down and γ-
phosphate moved out suggesting this does not reflect the actual ATP bound state (Figure 5) 
(Leonard et al., 2005). ParA switch II regions have differences in apo and nucleotide bound 
structures but not ATPγS and ADP structures (Figure 6C & D) (Pratto et al., 2008; Dunham 
et al., 2009). Although suggested for other proteins, only the structure of the Fe-protein 
shows the conformational change in the switch II region in response to presence of the γ-
phosphate making it the best model for this action.
Switch I is similar to switch II in terms of interactions with nucleotide phosphates and 
magnesium and in conformational changes dependent on nucleotide state. In the MinD/Mrp 
family the switch I loop contains a conserved aspartate, present in Get3, that appears to 
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position water for nucleophilic attack on the γ-phosphate unlike other ATPases where a switch 
II residue performs this function (Leipe et al., 2002). The structures of MinD with AMPPCP 
bound and ParA with ATPγS bound illustrate this interaction (Figure 9) (Hayashi et al., 2001; 
Pratto et al., 2008). In the Fe-protein, the conformation of switch I shows significant 
variability in different nucleotide states (Schlessman et al., 1998). Although a switch II residue 
could position the nucleophilic water, the conserved switch I aspartate is also present that 
could perform this function (Schindelin et al., 1997; Leonard et al., 2005). The hydrolysis 
inactivating mutation in the Soj ATP bound structure was to the conserved switch I aspartate, 
and the aspartate was suggested to position a nucleophile water (Leonard et al., 2005). In the 
structures of ArsA the interaction is not present. Analogous to switch II, changes in switch I 
interactions result in conformational changes, and of additional importance is a conserved 
aspartate involved in nucleotide hydrolysis.
Significant conformational changes in the relative position of the subunits in the 
homodimeric Fe-protein or changes in oligomeric state of MinD and Soj based on nucleotide 
state are critical for their function. The Fe-protein undergoes a ~13° rotation between the two 
subunits in the transition state to form the interaction site for the MoFe-protein (Figure 2A & 
B) (Schindelin et al., 1997). The interaction of the dimeric Soj with Spo0J upon ATP binding is 
analogous to the Fe-protein and MoFe-proteins in the nitrogenase complex. In the case of 
Soj, dimerization from monomers rather than a rotation between subunits makes Soj 
competent for Spo0J binding (Leonard et al., 2005). For MinD, ATP binding and dimerization 
have been proposed to expose the C-terminal amphipathic helix for membrane association 
(Hu and Lutkenhaus, 2003). Finally, the many conformations of ParA demonstrate the 
flexibility of the dimer in apo or ADP bound states (Figure 6A & B) (Dunham et al., 2009). 
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The different models for changes in the homodimeric state are key for understanding the 
function of  Get3.
Through sequence homology the MinD/Mrp family of P-loop GTPases, including Get3, 
appears to be closely related by evolution (Leipe et al., 2002). Examination of previous 
structural studies serves as a basis for examining the structure and molecular mechanism of 
Get3. Both the common themes and appreciable differences in the structure and function of 
related GTPases is important for connecting the structure of Get3 to its function as a 
nucleotide hydrolase. This defines its mechanism and part of the role it plays in TA protein 
translocation.
Binding TA Proteins
How TA proteins interact with Get3 is a fundamental question key to understanding the GET 
pathway. The hydrophobic TA presumably is involved in an interaction with a hydrophobic 
surface presented by Get3 and is also protected from the aqueous environment of the cytosol. 
Furthermore, nucleotide state and hydrolysis would be a mechanism for altering the 
interactions that bind and then release the TA protein. Although Stefanovic and Hegde 
proposed a putative TA protein binding site in Get3 based on a hydrophobic patch of residues 
(Stefanovic and Hegde, 2007), there are no obvious motifs for protein interactions in the 
sequence of Get3. The structure of Get3 is an obvious platform for identification and 
characterization of  the TA protein interaction site.
In terms of function the SRP is the closest molecular assembly to Get3. SRP54/Ffh is the 
universally conserved protein component of the SRP that binds to the hydrophobic signal 
sequence or anchor (reviewed in Keenan et al., 2001; Doudna and Batey, 2004) similar to Get3 
binding the TA. Interestingly, SRP54/Ffh is also a nucleotide hydrolase in the same SIMIBI 
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class as Get3 (Leipe et al., 2002). Unlike homodimeric MinD/Mrp family members, SRP54/
Ffh has GTPase activity stimulated by heterodimerization with the SR; however, the GTP 
hydrolase domains of the SRP and SR are homologous in sequence and structure. Three 
domains comprise SRP54/Ffh: an N-terminal four-helix bundle composing the N domain, the 
GTP hydrolyzing G domain and the signal sequence binding methionine-rich M domain.
Structures of SRP54/Ffh have given insight into the mechanism of signal sequence binding 
(Figure 10) (reviewed in Keenan et al., 2001; Doudna and Batey, 2004). The N and G domains 
are in close contact, but only a flexible linker connects them to the M domain. The M domain 
forms a hydrophobic pocket within a group of α-helices in conjunction with a flexible “finger 
loop” that could accommodate the signal sequence. How the NG domain couples nucleotide 
state with M domain signal sequence binding is a complex question given the many 
interactions of the three domains with the SRP RNA, ribosome, SR and the translocon. The 
SRP serves as an example of how a compact mechanism for protecting a diverse set of 
hydrophobic sequences from the cytosol can be made from a flexible hydrophobic pocket.
Summary
Protein translocation is a fundamental process in every organism. The SRP pathway is a 
universal mechanism for translocating many, but not all integral membrane proteins. TA 
proteins are a large and diverse class of integral membrane proteins that cannot be co-
translationally translocated and are instead post-translationally targeted via the GET pathway. 
The central component of the GET pathway is the MinD/Mrp family member ATPase Get3, 
which functions between Get4/5 and the ER membrane receptor Get1/2. Targeting by Get3 
is dependent on binding the TMD of TA proteins and ATP hydrolysis. This work gives 
insights into TA protein targeting by Get3 based on structural studies. Chapter 1 presents the 
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structure of Get3 and derives a model for tail-anchored protein binding coupled to nucleotide 
hydrolysis. Chapter 2 describes expression, purification and crystallization experiments on the 
complex of Get3 with TA proteins. Chapter 3 presents the structure of a tetrameric archaeal 
homolog of Get3, evidence archaeal Get3 can bind TA proteins and describes a model where 
a central hydrophobic chamber of  the Get3 tetramer sequesters TA proteins.
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Figures
Figure 1. The structure of conserved P-loop GTPase motifs.  A cartoon diagram of the 
monomeric subunit of the Fe-protein (PBDID 1N2C) bound to Mg (green sphere) and the 
transition state analog ADP·AlF4− (sticks) is a model for describing the P-loop GTPase 
motifs. The α-helices are colored cyan, β-strands yellow  and loops white. Motifs are colored: 
P-loop/Walker A/G1 (green), Switch I/G2 (magenta), Switch II/Walker B/G3 (blue), 
nucleotide specificity/G4 (pink) and A-loop/G5 (red).
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Figure 2. Structural alignment of the Fe-protein in different nucleotide states. (A) Fe-
protein dimer structure alignment shown as a cartoon diagram with cylindrical helices, 
nucloeotide in sticks and the spheres for the iron-sulfur cluster (orange and yellow) and 
magensium (green). The color scheme for motifs and secondary structure is the same as 
Figure 1. Apo (PBDID 2NIP, 1CP2) and transition state analog ADP·AlF4− bound (PDBID 
1N2C) structures are aligned by the right subunit to show  relative rotation in the left subunit 
in different nucleotide states (indicated with arrows). (B) Structures from (A) are colored red 
(2NIP, apo), white (1CP2, apo) and gold (1N2C, ADP·AlF4−). (C) As in (A) with the left 
subunit cut away to show  the NHD. Movements in the switch II region (blue, indicated with 
arrow) and iron-sulfur cluster (spheres, indicated with arrow) occur in the transition state 
and switch I flexibility is apparent in apo forms (magenta, indicated with arrow) (D) NHD 
from (C) colored as in (B).
21
22
Figure 3. Structural alignment of ArsA in different nucleotide states. (A) ArsA 
structures represented and aligned as in Figure 2 with antimony shown as purple spheres. 
ADP (PDBID 1F48), ADP·AlF3 (PBDID 1IHU), ATP (PDBID 1II0) and AMPPNP 
(PDBID 1II9) bound structures show  little overall conformational differences in between 
nucleotide states. (B) Structures from (A) are colored green (1F48, ADP), white (1IHU, 
ADP·AlF3), red (1II0, ATP) and blue (1II9, AMPPNP). (C) As in (A) with the left subunit 
cut away to show  the NHD. The NHDs are almost identical with minor changes in the 
position of  the A-loop (indicated with arrow) (D) NHD from (C) colored as in (B).
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Figure 4. Structural alignment of MinD in different nucleotide states.  (A) MinD 
structures represented as in Figure 2. Structures in apo (PDBID 1HYQ), ADP bound 
(PDBID 1G3Q, 1ION) and AMPPCP bound (PDBID 1G3R) forms show little differences 
in conformation except for switch I in apo form (indicated with arrow). (B) Structures from 
(A) are colored gold (1HYQ, apo), green (1G3Q, ADP), red (1G3R, AMPPCP) and white 
(1ION, apo).
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Figure 5. Structural alignment of Soj NHDs in different nucleotide states.  (A) Soj 
structures represented and aligned as in Figure 2. Structures apo (PDBID 1WCV), ADP 
bound (PDBID 2BEJ) and ATP bound (PDBID 2BEK) forms are shown. The apo form 
Switch II has minor differences in conformation (blue, indicated with arrow) and P-loop 
(green, indicated with arrow). (B) Structures from (A) are colored gold (1WCV, apo), green 
(2BEJ, ADP) and red (2BEK, ATP).
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Figure 6. Structural alignment of ParA in different nucleotide states. (A) ParA dimer 
structures represented and aligned as in Figure 2. Apo (PDBID 3EZ7, 3EZ9 chain B) and 
ADP bound (PDBID 3EZ2) forms show  a range of different conformations for the left 
subunit relative to the right subunit (indicated by arrow). (B) Structures from (A) are colored 
gold (3EZ7, apo), white (3EZ9) and green (3EZ2, ADP). (C) As in (A) with the left subunit 
cut away to show the NHD. The NHDs motifs also show  a wide variety of conformations. 
(D) NHD from (C) colored as in (B).
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Figure 7. Deviant Walker A motif lysines. (A) Inset (top) shows the top of the Fe-protein 
dimer relative to Figure 2. Bottom panel is close-up view (box from inset) of the deviant 
Walker A motif P-loop of the Fe-protein with ADP·AlF4− bound (PDBID 1N2C). 
Representation is the same as Figure 1 with the motifs colored in the left subunit. The 
conserved lysines (indicated with arrows) in the P-loop reach across the dimer interface to 
the opposite NHD to interact with the nucleotide phosphates. (B) As in (A) for the Soj 
dimer with ATP bound (PDBIB 2BEK).
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Figure 8. Switch II conformational changes with nucleotide state. (A) The NHD 
domain of the Fe-protein (PDBID 1N2C) shown as in Figure 1 with a stick representation 
of switch II side chains (indicated with dotted circle) and iron-sulfur cluster in spheres. In 
transparent gray is the apo form of the Fe-protein (PDBID 2NIP) showing the differences 
in conformations depending on nucleotide state. (B) ArsA bound to ADP·AlF3 (PBDID 
1HIU) compared to the ADP bound form (PDBID 1F48) shown as for (A) with metal 
ligands in spheres. There is little change in the conformation between the two states.
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Figure 9. Catalytic water positioned by Switch I aspartate. (A) NHD of MinD with 
AMPPCP bound (PDBID 1G3R) represented as in Figure 1. The conserved aspartate from 
switch I (stick representation, indicated with arrow) positioning a water (red dot, indicated 
with dashed circle) for nucleophilic attack on the γ-phosphate. (B) As in (A) for ParA with 
ATPγS bound (PDBIB 2OZE).
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Figure 10. SRP54/Ffh domains and hydrophobic binding pocket. Cartoon diagram of 
Ffh (PDBID 2FFH) shows the three domains: four-helix bundle N domain (green), GTPase 
G domain (blue) and methione-rich M domain (orange). The N and G domains have close 
interactions compared to the M domain. Hydrophobic residues (stick representation) line a 
hydrophobic groove formed by the helices and finger loop.
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C h a p t e r  1
A MODEL FOR TAIL-ANCHORED PROTEIN BINDING BY GET3
Introduction
Tail-anchored (TA) proteins represent a large and diverse class of integral membrane proteins 
that are found in all organisms. These include numerous types of proteins, such as SNAREs, 
apoptosis factors, and protein translocation components. TA proteins are characterized by 
having a single transmembrane helix (TM) at their extreme C terminus. Due to this topological 
constraint, these proteins are not able to follow the SRP-dependent co-translational pathway 
that typifies most integral membrane proteins. Instead, these proteins must find their correct 
membrane for insertion post-translationally (reviewed in (Kutay et al., 1993) and (Borgese et 
al., 2007)).
The ATPase Get3 was the first protein identified directly involved in TA targeting and is part 
of the Get pathway (now known as Guided Entry of Tail-anchored proteins) that also 
contains the ER membrane proteins Get1/2 and the putative ribosome receptor proteins 
Get4/5 (Schuldiner et al., 2005; Stefanovic and Hegde, 2007; Favaloro et al., 2008; Schuldiner 
et al., 2008; Jonikas et al., 2009). Multiple studies have shown that Get3 binds directly to the 
hydrophobic tail-anchors and, in conjunction with ribosome and endoplasmic reticulum (ER) 
factors, utilizes an ATP cycle to bind and then release TA proteins at the ER membrane.
Get3 was originally annotated Asna-1/Arr4p due to its apparent homology (≈25% identity) to 
the bacterial arsenite transporter component ArsA (Boskovic et al., 1996). Get3 homologues 
had been implicated in a diverse set of functions now presumed to be linked to the correct 
localizations of TA proteins (Shen et al., 2003; Kao et al., 2007; Tseng et al., 2007; 
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Hemmingsson et al., 2008). Get3 is a protein-targeting factor, analogous to the signal 
recognition particle (SRP), and, similar to SRP components (Hann and Walter, 1991), is not 
essential for viability in yeast; however, the cells are sensitive to a variety of stresses such as 
heat and metals (Zúñiga et al., 1999).
Get3 contains a nucleotide hydrolase domain (NHD) that resembles the G-type hydrolases 
characterized by Ras (for review see (Sprang, 1997)). These proteins all have the completely 
conserved ‘P-loop’ that recognize the α- and β-phosphate in both NDP and NTP states. 
Other features of G-type hydrolases are Switch I (A’) and Switch II (Walker B) loops that 
undergo dramatic rearrangements coupling structural changes to the presence of the γ-
phosphate. In these proteins, catalysis is stimulated by a positively charged residue that 
stabilizes negative charge on the phosphates and a residue that positions a catalytic water for 
nucleophilic attack.
Get3, like ArsA and the nitrogenase iron protein (NifH), belongs to a special class of ATPases 
that contain a ‘deviant’ Walker A motif which is a P-loop with an additional invariant lysine 
(GKGGVGKT in Get3) (Koonin, 1993). This is a rare motif, found in only two other yeast 
proteins (including a putative Fe-protein homologue (Netz et al., 2007)). A basic model for the 
deviant P-loop ATP hydrolysis cycle can be inferred by the structure of a NifH dimer bound 
to ADP·AlF4− and its partner the MoFe protein (Schindelin et al., 1997). The ADP and apo 
forms of NifH are in an open conformation that is inactive for ATP hydrolysis (Schlessman et 
al., 1998). Binding of the MoFe protein, along with ATP, causes a large rotational and 
translational shift of the two NifH monomers that brings the deviant P-loop lysine from the 
opposing monomer into a position to stabilize the build up of negative charge on the 
phosphates. This is analogous to the mechanism in Ras where an Arg-finger from a GAP 
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stimulates hydrolysis of ATP leading to Ras inactivation (Milburn et al., 1990; Scheffzek et al., 
1997). This interface shift demonstrates how ATP can modulate dramatic structural changes. 
Critical to all of this, the rearrangements are stabilized by binding of the MoFe protein 
(Schindelin et al., 1997). In the case of ArsA, without its partner ArsB bound, no states are 
found in which both NHD bind the same nucleotide and it is reasonable to speculate that in a 
true ATP state a dramatic conformational change must occur as well (Zhou et al., 2001; 
Lutkenhaus and Sundaramoorthy, 2003).
There are no mechanistic studies detailing how Get3 performs its important targeting function 
and a molecular level understanding requires structural information. Here we present three 
crystal structures of Get3/TRC40, a monomeric apo form from Saccharomyces cerevisae (ScGet3) 
and dimeric apo and hexameric ADP-bound forms from the thermophilic opportunistic 
human pathogen Aspergillus fumigatus (AfGet3 and AfGet3-ADP). Based on the structures, we 
probed functional interfaces and essential residues by phenotypic rescue. Our results allow us 
to define a model of how Get3 couples ATP hydrolysis to the binding and release of TA 
proteins. More broadly, this work supports a mechanism for a special class of  ATPases.
34
Results
Crystallization of  Get3
We purified ScGet3 and AfGet3 from constructs expressed in E. coli using Ni-affinity and size 
exclusion chromatography under reducing conditions. The majority of the protein eluted as a 
dimer from both constructs and this was used in crystallization trials. The AfGet3-ADP 
crystals diffracted to 3.2Å resolution in the space group P212121 with a hexamer in the 
asymmetric unit. A seleno-methionine data set was collected to 4.5Å resolution and phases 
were solved by multiwavelength anomalous dispersion and extended to 3.2Å resolution using 
the 6-fold noncrystallographic symmetry. The final refined structure contained 292 of 348 
residues with a Free-R factor of 25.1% (Fig. 1C and Fig. S1). The two Apo forms of Get3 
were solved using molecular replacement of a truncated AfGet3-ADP monomer. The ScGet3-
apo crystal form diffracted to 3.7Å resolution in the space group H32 and contained a 
monomer in the asymmetric unit. The final model contained 260 of 369 residues and refined 
to a Free-R factor of 33.5% (Fig. S2 A and B). The AfGet3-apo crystal form diffracted to 7.5Å 
resolution in the space group P4232 and contained a dimer in the asymmetric unit that we did 
not refine due to the low resolution (Fig. S2D). Crystallographic statistics are provided in 
Table S1.
Description of  a Get3 Monomer
The structure of a monomer of Get3 is a mixed alpha-beta fold containing a ‘‘P-loop’’ type 
NHD with two α-helical loops that extend outward from the structure, here designated 
substrate binding loop 1 (SB1) and 2 (SB2) (Fig. 1 A and B). The Get3 NHD fold falls into a 
more specific structural class (defined by SCOP (Andreeva et al., 2008)) that includes ArsA 
(Zhou et al., 2000), GTPase domains of the signal recognition particle (SRP) (Freymann et al., 
35
1997), and SRP receptor (Montoya et al., 1997) along with NifH (Georgiadis et al., 1992). 
Get3 is the only eukaryotic example in this class that utilizes ATP.
The Three Crystal Forms of  Get3
The Af-ADP crystal form contains a hexamer in the asymmetric unit (Fig. 1C) with 3-fold 
symmetry in which the monomer can be assembled into two potential dimers formed by 
either SB1/2 (arm dimer) or by the interface between the NHD (Fig. 1 B and D). Although 
the arm dimer contains a more extensive interface, 1758Å2 versus 1263Å2 calculated by PISA 
(Krissinel and Henrick, 2007), we believe that the NHD dimer is the most relevant to TA 
protein binding and contains two disulfides formed across the interface by a conserved pair of 
cysteines (Fig. 1B).
The Sc-apo crystal form contains a monomer in the asymmetric unit (Fig. 1E and Fig. S2A) 
and there is no apparent NHD dimer interface despite the protein purifying as a dimer. The 
crystals are stabilized by the coordination of a zinc by Cys-285/Cys-288 and the His-tag which 
also coordinates a second metal at the crystallographic three fold in a square-planar geometry 
(Fig. S2A). The AfGet3-apo contains two copies in the asymmetric unit in an orientation 
similar to the NHD dimer, although rotated so that the SB1 and SB2 regions of the two 
monomers are slightly closer (Fig. S2E). Both Apo crystal forms contain symmetry related 
interfaces similar to the arm dimer (Figs. S2C and S3F).
Monomers in each of the three crystal forms show slight variations in SB1/2 demonstrating 
the general mobility of these regions (Fig. 1E and Fig S2F). These loops in the hexamer are 
stabilized by a series of hydrophobic interactions in a highly flexible region that perhaps 
explains the difficulty in obtaining high-resolution crystals. SB1 and SB2 contain disordered 
regions in all of the crystal forms. The missing residues of SB1 have been modeled into the 
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AfGet3-ADP hexamer to demonstrate the amount of disordered protein that could not be 
built (Fig. 1C).
Nucleotide Binding
The Get3 nucleotide-binding pocket contains all of the features generally found in G-type 
hydrolases. The completely conserved Asn in S7 (Sc/Af272) forms hydrogen-bonds that 
specifically select for adenine. Additional interactions with the A-loop complete adenosine 
recognition (Fig. 2A). The P-loop, as is typical, makes extensive contacts to the α- and β-
phosphate; however, the second lysine, completely conserved in P-loops, is in an orientation 
that points away from the β-phosphate. This is caused by an interaction in the arm dimer that 
leads to an Arg from SB2 (Af200) moving into the active site occupying a similar position near 
where one would expect Mg2+ to be bound (Fig. 2 A). It is clear that AfR200 displaces the 
Mg2+ and generally disrupts the interactions of Switch I and II. Based on the resolution, we 
cannot be certain that there is no Mg2+; however, if present it would be in a unique position. 
AfR200 forms a salt bridge to the β-phosphate; but it is not conserved making the extent of 
these interactions surprising.
Comparison to ArsA and NifH
Despite distinct functions, Get3 shares a similar topology to ArsA with an RMSD of 1.9Å in 
their NHD (Fig. 2B) (PDBID 1f48) (Zhou et al., 2000). In contrast to Get3, ArsA SB1/2 bend 
in across the NHD dimer interface forming a coordination site for heavy metals (Fig. 2A); 
however, these coordinating residues are not conserved in Get3. It is thought that motions of 
these loops are coupled to ATP hydrolysis regulating metal release via the Switch II motif 
(Zhou et al., 2001). The dimer interface is very similar to Get3 except that the interface is 
rotated moving the P-loop from 9.1Å (G17/G336) separation in ArsA to 14.1Å (AfG35) in 
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Get3. An early homology model of Get3, based on ArsA, predicted the occurrence of the 
disulfide bridges between the subunits at the dimer interface. Based on the model they found 
that mutation of the two cysteines in Get3 was unable to rescue a metal sensitivity phenotype 
in a Get3 knockout (Metz et al., 2006). ArsA is a pseudodimer with a disordered linker peptide 
between the two subunits that may be required to stabilize the dimer interface.
The best understood deviant P-loop protein is NifH as its structure has been solved in Apo, 
ADP, and ADP·AlF4− forms. The structure closest to AfGet3-ADP is the NifH-Apo form 
(Schlessman et al., 1998) and the NHD domains have an RMSD of 2.78Å. As noted, ATP 
stimulates a large conformational shift that moves the deviant P-loop (A. vinelandii NifH G11) 
from 10.1Å to 4.0Å apart. To move the Get3 dimer into a similar orientation would require an 
extensive conformational change across the dimer interface.
Tail-Anchor Binding Pocket
In a search for the TA protein binding pocket, the positions of SB1 and SB2 are clearly 
provocative. We analyzed the NHD dimer by displaying conserved and hydrophobic residues 
on a molecular accessibility surface (Fig. 3). The interface, formed by the NHD dimers, is 
highly conserved, as is expected for a common fold (Fig. 3A). The other concentration of 
conserved residues is found at the base and groove formed by SB1/SB2 (Fig. 3C). The overall 
alignment of SB1/SB2 is difficult; however, there is general conservation of hydrophobic 
residues and glycines (Fig. S1). Additionally, SB1 contains a disordered stretch that could also 
provide surface area in this region. The only hydrophobic patch on the surface of the dimer is 
that formed between SB1 and SB2 (Fig. 3 B and D). This putative TA-binding region would be 
analogous to the location of the metal binding sites of ArsA or the Fe-S cluster in NifH (Fig. 2 
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B and C) and one presumes that changes in the ATP binding pocket would be transmitted to 
this region.
Phenotypic Rescue
To probe the functional parts of Get3 we chose a series of mutants based on surface 
conservation or putative function and tested for their ability to rescue known knockout 
phenotypes (Metz et al., 2006). The knockout (Δget3) showed no obvious impairment on 
synthetic complete media at 30C but was unable to fully rescue on media containing Cu2+ or 
hydroxyurea or growth at elevated temperature. Replacing the Get3 gene on a plasmid (GET3) 
with the wild-type promoter rescued the Δget3 growth to near wild-type levels. We also 
inserted the AfGet3 gene on the same plasmid and this also rescued the yeast knockout 
demonstrating that functional aspects of the protein are conserved across species (Fig. 4A and 
Fig. S3). In all, we generated 69 Sc mutants and two Af mutants and scored their general loss-
of-function (LOF) phenotype as strong, moderate, weak or none (Fig. 4A and B, data for all 
mutants in Fig. S3 and Table S2).
In agreement with previous results, a mutation in either the P-loop (ScG30R or AfG38R) or 
the pair of Cys that form the disulfide bridges (C285T/C288T) had strong LOF phenotypes 
(Fig. 4A) (Schuldiner et al., 2005; Metz et al., 2006). The G30R mutation is thought to disrupt 
ATP binding. The effect of the Cys mutants is less clear. Presumably, this interface is 
somewhat unstable and requires the disulfides to stabilize the dimer, similar to the linked dimer 
of ArsA. As the cytoplasm is a reducing environment, it would be curious that the disulfides 
could form in vivo; however, we included reducing agent in all of our buffers and the 
disulfides formed in that context. Another possibility is that these residues coordinate a metal 
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or are regulated by a redox pathway (Metz et al., 2006) as the reduced form in the ScGet3-apo 
crystals is a monomer and coordinates a zinc (Fig. S2 A and B).
The largest cluster of LOF mutants occurs at the NHD dimer interface found mostly on H8 
and H9. The interface is a mixture of hydrophobic and charged groups that would be 
intimately involved in a re-arrangement of the dimer (Fig. S4B, Figs. S1 and S4A). Only a few 
of the conserved surface mutations that did not make contacts in this crystal form conferred 
LOF phenotypes (R75A, D265A, and Y338A) and probably do not affect the conformational 
changes in substrate binding (Fig. S4B). It is possible that these surface residues play a role in 
recognition of  other proteins in the Get pathway.
Changes in switch helices are normally coupled to functional changes. Although there was little 
conformational change in ArsA nucleotide structures, it was postulated that binding of ATP 
would cause a conformational change in Switch II that would be transmitted to a His involved 
in metal coordination (Zhou et al., 2001). This residue (ScH172) is the only coordinating 
residue from ArsA that is found in Get3 and in our structure this is in a position to interact 
with a network of salt bridges that appear to stabilize the base of SB1/2 (Fig. S4C). Mutations 
of these residues had LOF phenotypes; however, they were not strong and it may be possible 
that coupling of  Switch II changes is not essential for TA binding.
Get3 binds a variety of TA protein substrates via hydrophobic interactions (Stefanovic and 
Hegde, 2007) and it is difficult to decide what mutations might interfere with binding. Based 
on the predicted pocket, we generated extensive mutations in SB1 and SB2. As expected, 
mutations in the predicted TA protein binding pocket (I136S, D137A, L140S, S141A, M143S, 
and L219S) had LOF; however, the majority of the residues had no phenotype including those 
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disordered in our structure (Fig. 4B and Fig. S4D). This hydrophobic interaction may require 
multiple mutations in the binding pocket to see significant disruptions.
The lack of conservation of the SB2 residue AfR200 made a comparable mutation in Sc 
impossible. Due to its location in the nucleotide-binding pocket in the AfGet3-ADP structure 
we decided to see if its mutation would have an effect on rescue by AfGet3. An AfR200A 
mutation was a clear LOF phenotype (Figs. 2A and 4A). This is in contrast to a number of 
other mutations, including some disordered residues, in this region of SB2 that showed no 
phenotypes. It is difficult to envision an effect of the AfR200A mutation in the absence of the 
hexamer.
A mutation of the conserved deviant P-loop lysine is expected to completely abolish function 
and should be a strong phenotype. In the AfGet3-ADP structure this residue makes no 
contacts (Fig. 4 and Fig. S4A), still, a mutation of this residue to Ala (ScK26A) was the 
strongest phenotype of all. In the Ras/ RasGAP case any mutation of the Arg-finger leads to 
a total LOF even for the seemingly benign mutation to Lys (Ahmadian et al., 1997). We did the 
same type of mutation, ScK26R, and found that this mutant is a strong LOF phenotype, 
although not as strong as ScK26A.
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Figures
Figure 1. Structures of Get3.  (A) An AfGet3-ADP monomer with secondary structure 
elements numbered as in Fig. S1 (B) The NHD dimer of the AfGet3-ADP hexamer. One 
monomer is color ramped from N- (blue) to C- (red) and the other is colored relative to 
motifs described in the text: P-loop (green), Switch I (magenta), Switch II (blue), A-loop 
(red), SB1 (purple), and SB2 (brown). (C) The AfGet3-ADP hexamer of the asymmetric unit 
colored by monomers. Dimer interfaces and subunits are labeled. The 3-fold is indicated by a 
triangle and 2-folds are indicated by an oval. The modeled residues from SB1 of each 
monomer are transparent. Nucleotides and bridging disulfides are shown as spheres. (D) The 
arm dimer of the AfGet3-ADP hexamer. One monomer is color ramped as in A and the 
other is colored salmon. (E) The ScGet3 model colored purple and overlayed with an 
AfGet3-ADP monomer colored and oriented as in B.
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Figure 2. The nucleotide-binding pocket and comparison of Get3 to other 
hydrolases. (A) The nucleotide-binding pocket of AfGet3-ADP with residues shown as 
sticks. Density is a 2Fo-−Fc omit-map contoured at 1.5σ. (B) A ribbons diagram of the ADP 
form of EcArsA (1f48) with ADP, Mg2+ (green) and coordinated Sb (purple) as spheres. (C) 
A ribbon diagram of the apo form of NifH (2nip) with the Fe/S cluster (orange/yellow) as 
spheres. To the right in B and C are overlays of monomers the AfGet3-ADP monomer 
(gray) on the respective left subunit. Important residues and motifs are labeled. All residues 
in nucleotide binding motifs are colored as in 1B.
43
Figure 3. Conserved and hydrophobic surfaces. (A) Front and back views showing one 
monomer as a ribbon colored as in 1A and the other as an accessible surface showing 
conservation colored as a gradient from 100% (purple) to 50% conserved (gray). 
Conservation is based on the Get3 alignment from Fig S1 (B) Similar to A showing 
hydrophobicity based on the Kyte and Doolittle scale with most hydrophobic in dark yellow. 
(C) Conserved surface viewed from the top. (D) Hydrophobic surface viewed from the top.
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Figure 4. Phenotypic rescue of various Get3 mutants. (A) Spot plate assays of various 
yeast mutants on a plasmid with a wild-type promoter screened on SC-Ura plates at 30C and 
40C and supplemented with 2 mM CuSO4 at both 30C and 37C. ΔGET3 is the knockout 
transformed with a plasmid containing only the promoter. Mutants based on yeast 
numbering are indicated colored relative to their phenotype: strong (red), moderate (orange), 
weak (yellow), and none (cyan). (B) Two views with one monomer as accessible surface and 
the other in ribbon colored according to phenotype as in A.
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Figure 5. NifH-like model.  (A) An overlay of AfGet3-ADP in the open dimer and the 
closed NifH (1m34)-like model. The AfGet3-ADP dimer, similar to Fig. 1B, is colored with 
the right monomer by feature and the left in purple. The modeled rotated monomer is in 
light blue. AfK34 and the bridged cysteines shown as spheres. Arrows indicate direction of 
motion. (B) Conserved surface of the NifH-like model oriented as left A. (C) Hydrophobic 
surface of  the NifH-like model orientated as right A.
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Discussion
Get3 must couple ATP hydrolysis to TA protein binding and release. To propose a mechanism 
for Get3 binding of TA proteins we can model the transition to a closed-bound state based on 
the NifH structures. We believe our structures represent various open, non-substrate binding 
conformations where the hydrophobic SB1/2 are highly flexible and open for interaction with 
proteins, possibly in a metastable hexameric state. The binding of ATP couples to a 
rearrangement of the Switch loops that would be transmitted to SB1/2. Binding would also 
involve a rotation and translation at the dimer interface that moved the bridging ScK26 (Af34) 
into a position to counter the additional charge of the γ-phosphate (modeled in Fig. 5A). The 
AfGet3-apo dimer shows how some of this motion could occur as it rotates inward, relative 
to the AfGet3-ADP dimer, demonstrating flexibility at this interface (Fig. S2E). There are 
clashes in this simple NifH-like model and we believe that additional conformational changes 
must occur.
This ATP bound complex would bury a considerable amount of the conserved residues at the 
dimer interface (Fig. 5B) and would bring SB1/2 from opposing dimers into a closer 
orientation, creating a large hydrophobic groove at the top of the interface (Fig. 5C). This 
structure would be incompatible with our hexamer but would provide a favorable binding 
surface for a TA protein. The TM helix would dock in the groove formed at the base of SB2 
and the hydrophobic flexible loop of SB1 could then wrap around it, similar to SRP signal 
sequence finger-loop binding (Schaffitzel et al., 2006). The only component missing in such a 
model is the residue that would activate the catalytic water. It is possible that additional partner 
binding at the membrane would either donate this group or lead to additional conformational 
changes in Get3 that would stimulate ATP hydrolysis once the substrate has been delivered.
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The oligomeric state of Get3 based on this work leads to open questions about function. By 
homology to NifH and ArsA, we have described a model in which the NHD dimer 
interactions are the most relevant to TA protein binding; however, we find it difficult to ignore 
the arm dimer interface. In all of our crystal structures, SB1/2 interactions bury a significant 
amount of hydrophobic surface implying that they have a high affinity for binding protein 
(Fig. 1D and Fig. S2 C and F). In an open form these surfaces should be very unstable and it is 
hard to imagine that they could exist free in the cytoplasm. The hexamer seen in our crystal 
structure could be a stable resting form of the protein that needs additional factors, such as 
the Get4/Get5 proteins (Jonikas et al., 2009), to transition to the open dimer state. Another 
possibility is that the hexamer operates as an ADP-exchange factor (like a GEF for Ras) 
stabilizing the apo form for ATP binding by displacing the Mg2+ and releasing ADP. In 
AfGet3 the R200 salt bridges to the ADP β-phosphate, which would seem to stabilize the 
ADP form; however, the concentration of ADP in our crystal conditions is very high and the 
binding could be an artifact of that. A third, less likely, possibility would be that the hexamer is 
the active form of the complex and that TA proteins are stabilized in the flexible hydrophobic 
center reminiscent of some AAA ATPases (Ogura and Wilkinson, 2001). Evidence that 
supports a role for the hexamer is the importance of AfR200, a purified human Get complex 
sediments at a compatible size (Stefanovic and Hegde, 2007), the functional form of ArsA is a 
multimer (Ching et al., 1991), and a trimeric form of ArsA has been visualized by EM and 
chromatography (Wang et al., 2000).
Proper synthesis and targeting of TA proteins by the Get pathway have broad implications in 
biology, as they are essential in many cellular homeostasis and transport processes. Our 
structural and functional studies are a mechanistic look at the recently identified pathway 
component Get3. These experiments allow us to define a model that predicts the 
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conformational changes in Get3 that are involved in TA protein and nucleotide binding (Fig. 
S5). They also suggest an oligomeric form that may play a key role. Many aspects of TA 
protein targeting, such as the specifics of substrate binding, interactions of partners and the 
kinetic steps of  recognition and release, remain to be determined.
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Materials and Methods
Cloning, Expression, and Purification
The A. fumigatus Get3 coding sequence was synthesized by PCR using primers designed with 
DNAWorks (Hoover and Lubkowski, 2002), and the S. cerevisiae GET3 gene was amplified by 
PCR from genomic DNA, both with NcoI and XhoI restriction sites added. Amplified DNA 
fragments were NcoI/XhoI digested and ligated into pET33b (Novagen) to create C-terminally 
6×His tagged constructs.
A. fumigatus and S. cerevisiae Get3 proteins were recombinantly expressed in E. coli BL21-
Gold(DE3) cells grown in 2× YT medium for 3 h. at 37 °C after induction with 0.3 mM 
isopropyl-β-D-thiogalactopyranoside. Get3 was purified by Ni-NTA affinity chromatography 
and gel filtration on a Superdex 200 16/60 column (GE Healthcare). Fractions from gel 
filtration were concentrated to 10–15 mg/mL of protein and dialyzed in a buffer of 5 mM 
Tris, pH 7.5, and 6 mM beta-mercaptoethanol (βME) for crystallization.
Crystallization and Structure Determination
All crystals were grown by the sitting-drop vapor diffusion method with a 1:1 ratio of protein 
to precipitant solutions at 23°C. ScGet3-apo crystals were obtained in 0.1 M HEPES pH 8.0, 
1.6 M ammonium sulfate and 6 mM βME, AfGet3-apo crystals in 0.1 mM bis-Tris, pH 7.0, 
0.2 M NaCl, 1.5 M ammonium sulfate and 6 mM βME, and AfGet3-ADP co-crystals in 0.2 M 
potassium citrate, 16% (wt/ vol) polyethylene glycol 3350, and 6 mM βME, with the protein 
solution supplemented with 2 mM ADP and 1 mM MgCl2. ScGet3-Apo were cryoprotected 
by transfer to 3.4 M sodium malonate (pH 7), and AfGet3-Apo crystals and AfGet3-ADP co-
crystals were serially transfered to artificial mother liquor supplemented with 20% (wt/vol) 
sucrose and 20% (wt/vol) xylitol and with 20% ethylene glycol, respectively. All crystals were 
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flash-frozen to 100 K by direct transfer into liquid nitrogen. Selenomethionine (SeMet) 
derivatives of  AfGet3 were handled in the same manner as the native protein.
All diffraction data were obtained on Stanford Synchrotron Radiation Lightsource beam line 
12–2 at the SLAC National Accelerator Laboratory, at 100 K. (Table S1). Diffraction data 
were integrated with MOSFLM and scaled with SCALA (Leslie, 1992; Evans, 2006). Multiple-
wavelength anomalous dispersion (MAD) data from a SeMet derivative of AfGet3-ADP 
allowed the assignment of forty-nine selenium sites using SHELXD, and experimental phases 
were calculated by SOLVE with an overall figure of merit of 0.63 (Terwilliger and Berendzen, 
1999; Sheldrick, 2008). BUCCANEER performed density modification and built an initial 
model, and the complete model was manually built in COOT (CCP4, 1994; Emsley and 
Cowtan, 2004).
Refinement against the 3.2Å resolution native AfGet3-ADP data used strict 6-fold NCS 
symmetry and consisted of cycles of simulated annealing and group B-factor refinement in 
CNS followed by manual rebuilding (Adams et al., 2002; Painter and Merritt, 2006a). 
Unambiguous density was observed for residues 12–106, 125–189, 195–277, and 282–338 in 
all monomers. The overall topology is shown in Fig. S2A. Density was observed for residues 
190–194 in the SB2 loops but could not be confidently modeled. Residues 195–200 were 
modeled individually into each monomer. TLS groups were determined using the TLSMD 
web server and NCS restraints were relaxed to allow variation between subunits for final 
refinement in PHENIX to yield an R-factor of 21.2% and an R-free of 25.13% (Adams et al., 
2002; Painter and Merritt, 2006a).
Molecular replacement of the ScGet3-apo dataset was performed with PHASER (McCoy, 
2007). The search model was prepared from the AfGet3 ADP structure by removing SB1 loop 
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residues 98 to 129, SB2 residues 177 to 214, and residues 282–288 of H9. A single copy was 
located in the asymmetric unit and the initial weighted 2 Fo − Fc maps showed density that 
allowed rebuilding of H9, an extension of the C terminus by 11 residues to form a helix that 
packs against S8, and shifts in H5, H6, and H7 (Fig. 1E and Fig. S1A).
An anomalous difference map contained a strong peak between C285 and C288 and a second 
peak at the proximal 3-fold axis special position. X-ray fluorescence spectroscopy indicated 
that the crystal contained zinc. Density between the two peaks could be modeled as the C-
terminal hexahistidine tag used in purification as an extended strand, resulting in square planer 
coordination of a metal between the two cysteines and two histidines, and octahedral 
coordination at the special position by symmetry-related histidines.
After a manual rebuild, the helices and the β-sheet were refined as rigid bodies and one 
isotropic B-factor was refined per residue. Hydrogen bond and φ/ψ angle restraints allowed 
for torsion angle simulated annealing in CNS and PHENIX while preserving secondary 
structure geometry. The refined model consisted of residues 8–89, 137–190, 217–277, 284–
316, and 320–356 with an R-factor of  28.1% and an R-free of  33.5%.
The truncated AfGet3-ADP search model was also used for molecular replacement of the 
AfGet3-apo data. Density was observed in the weighted 2 Fo − Fc maps corresponding to the 
SB2 region (Fig. S2D). Two copies were located in the asymmetric unit in a relative orientation 
similar to the NHD dimer although rotated so that the SB1 and SB2 regions of the two 
monomers are slightly closer (Fig. S2E). Symmetry related copies form dimers similar to the 
arm dimer (Fig. S2F). No further refinement of  the apo structure was performed.
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Figs. 1, 2, 4, and 5A, Figs. S2, and S4 were prepared using PyMOL (Schrödinger, LLC). Figs. 3 
and 5 B and C were prepared using UCSF Chimera (Sanner et al., 1996; Pettersen et al., 2004).
Growth Assays
The promoter region of GET3 was amplified from genomic DNA by PCR with XbaI and 
NcoI restriction sites and ligated 5’ to A. fumigatus and S. cerevisiae GET3 in the pET33b 
constructs. The promoter region, promoter region with S. cerevisiae GET3 and promoter 
region with A. fumigatus GET3 were each amplified by PCR with XbaI and NcoI restriction 
sites added and cloned into YEp352 vector (ATCC). GET3 mutants were generated by site-
directed mutagenesis. YEp352 constructs were transformed into BY4741 and BY4741 
YDL100c::kanMX4 cells (ATCC) for use in growth assays.
Growth defects of GET3 knockouts complemented with GET3 mutants in YEp352 on drop 
plates were scored were given one of three scores: weak, moderate and strong. Growth defects 
weaker than the knockout were categorized as weak if they were closer to the WT and 
moderate if they were closer to the knockout. Growth defects similar to or greater than the 
knockout were classified as strong. We determined the consensus score by taking the strongest 
growth defect among the different growth conditions and averaging it between the duplicates 
from separate experiments.
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Supplemental Figure 1. Sequence alignment of Get3 homologues. Sequences were 
aligned using the program ClustalX (Larkin et al., 2007). Residue coloring is based on the 
program output (colored based on amino acid type). The species in order are Scere (S. 
cerevisiae), Afumi (A. fumigatus), Spomb (Schizosaccharomyces pombe), Dreri (Danio rerio), Xlaev 
(Xenopus laevis), Dmela (Drosophila melongaster), Celeg (Caenorhabditis elegans), Athal (Arabidopsis 
thaliana), and 1F48N and C (the N and C-terminal sequence of E. coli Arsa). Numbering, 
from top to bottom, is based on Sc, Af, and EcArsA with disordered residues in ScGet3, 
AfGet3-ADP and PDBID 1f48 colored in red. Secondary structure for AfGet3-ADP is 
shown on top, along with numbering as in Fig. S2 A, and the N terminus of 1f48 is shown 
on the bottom, α-helices as red rectangles and β-sheets as yellow arrows. Structural elements 
discussed in the text are in boxes above the alignment colored as in Fig. 1B. Below  the 
alignment, gray bars show  degree of conservation at a given position based on Get3 
sequences. Mutations described in the text are indicated by asterisks for Sc (*) and pound for 
Af (#) colored strong (red), moderate (orange) and weak (yellow) for LOF phenotypes and 
cyan for mutants that did not display a phenotype in our assays. Gray diamonds (filled 
diamonds) represent residues in ArsA that coordinate metal binding.
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Supplementary Figure 2. The ScGet3 (A–C) and AfGet3 (D–F) crystal forms. (A) The 
ScGet3-apo monomer with labeling and color similar to Fig. 1 A. The modeled zinc (slate) 
and putative Ni (green) are shown as spheres with coordinating side-chains from the 
monomer as sticks. (B) A composite omit map contoured at 1σ with the protein model in 
sticks colored as in A. (C) Opposing crystallographic ScGet3-apo dimer showing the oriented 
SB1/2 loops that interact in the crystal lattice. One monomer is colored by motifs and the 
other is in salmon. The SB1/2 loops are generally disordered and not clearly interpretable in 
our structure. (D) A monomer of the AfGet3-apo dimer found by molecular replacement. 
Only the portions of the AfGet3-ADP structure used as a search model are shown. Density 
is a 1.2σ map calculated using phases from the molecular replacement solution. Additional 
density for the truncated SB2 can be seen. (E) The NHD dimer interface is slightly different 
in the apo form. We have modeled this movement using the AfGet3-ADP form. That dimer 
is in gray, and the movement in the apo form is modeled in purple. (F) The arm dimer seen 
in the crystal packing for the apo form. Loops are poorly ordered and the ADP form is 
modeled as transparent helices for clarity.
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Supplementary Figure 3. Mutant rescue experiments.  The full panel of yeast mutants 
similar to Fig. 4 A. Subpanel letters indicates a group of mutants plated together, one plate 
for each growth condition. Every plate contained the parent strain, knockout strain and 
plasmid complemented transformant as functional controls. Growth defects were tested on 
SC-Ura supplemented with 2 mM CuSO4 at 30° C and 37° C, 200 mM hydroxyurea at 30° C, 
and SC-Ura at 40° C. SC-Ura at 30° C was used as a growth condition control. Experiments 
not performed are highlighted by hashed rectangles. Our interpretation of these results is 
indicated in Table S1.
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Supplemental Figure 4. Phenotype regions described in the text. (A–D) On the left are 
zoomed in views of the regions described in the text. Residues are shown as sticks and 
colored as in 4B and some of the phenotype residues are labeled. Hydrogen-bonds are 
shown as gray dashes. On the left is a ribbon diagram of the full dimer in the same 
orientation with a few  of the residues drawn as sticks for orientation. The dashed boxes 
indicated the approximate region shown on the right.
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Supplemental Figure 5. Model for tail-anchored recognition. The discussion suggests 
the following model. In a resting/open form Get3 may alternate between (1) a hexamer and 
(2) a NHD dimer. Binding of ATP would lead to a conformational change that would 
facilitate formation of a stable complex with a TA protein. Binding of both would result in a 
complex (3) primed for ATP hydrolysis. Additional conformational changes or partner 
binding would stimulate ATP hydrolysis. Loss of the inorganic phosphate (Pi) would lead to 
release of  the TA protein and a return to the open form.
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AfGet3-ADP AfGet3-ADP MAD ScGet3-apo AfGet3-apo
Data collection
Space group P212121 P212121 H32 P4232
Cell dimensions
    a, b, c (Å)
67.76, 154.78, 
242.88
68.72, 155.51, 242.72
115.32, 115.32, 
281.11
181.02, 181.02, 
181.02
    α, β, γ (°) 90, 90, 90 90, 90, 90 90, 90, 120 90, 90, 90
Resolution (Å) 50-3.2(3.37-3.2) 50-4.5(4.74-4.5) 50-3.7(3.9-3.7) 50-7.5(7.91-7.5)
Peak Inflection Remote
Wavelength (Å) 1.00000 0.97941 0.97954 0.91837 1.00000 1.00462
Rmerge (%) 12.4(66.7) 8.0(13.4) 7.7(12.0) 7.7(12.5) 9.9(62.7) 6.4(41.3)
I / σI 10.4(2.5) 18.0(12.7) 19(13.5) 18.6(13.5) 8.9(2.7) 16.9(3.9)
Completeness (%) 100.0(100.0) 100.0(100.0) 100.0(100.0) 100.0(100.0) 99.9(100.0) 97.1(97.9)
Redundancy 4.9(5.0) 7.3(7.5) 7.3(7.5) 7.3(7.5) 5.9(6.0) 5.0(5.2)
Refinement
Resolution (Å) 50-3.2 50-3.7
No. reflections 43100 7936
Rwork / Rfree (%) 21.2/25.13 28.1/33.5
No. atoms
    Protein 14082 2184
    Ligand/ion 156 2
B-factors
    Protein 86 182
    Ligands/Ions 71 120
Bond RMSD
    Lengths (Å) 0.01 0.007
    Angles (°) 1.362 1.147
High-resolution shell in parenthesis.
Supplementary Table 1. Crystallographic statistics
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Numbering Phenotypes Figure S3 Plate set
ScGet3 AfGet3
2mM Cu 
30°C
2mM Cu 
37°C
200mM 
HU 30°C
40°C overall
E6A E14 W W C, D
T17A T25 W W W E, I
K19A R27 E, I
K26A K34 S S S S S F, I
K26R K34 M M M S S F, I
G30R G38 S S S S S C, D
H60A H66 W + F, I
D64S D70 S S W M S E, I
K69A K75 + W M +/M C, D
K72A K78 W F, I
D73A D79 W F, I
R75A R81 W W W W W A, D
E87A E93 S M W W S E, I
D89A D95 E, I
V102S I100 W A, D
A105S L103 W W F, I
L117S L115 W W W W F, I
L120S L118 F, I
G123P G121 F, I
A125S M123 W W W W A, D
L126S M124 C, D
D128A D126 W W A, D
L129S L127 F, I
I133S I131 W F, I
I136S V134 W W W W A, D
I136D V134 W W W F, I
D137A D135 W W W W A, D
E138A E136 W W W W E, I
L140S M138 W W M W A, D
S141A S139 W W W M M A, D
M143S A141 W W W W W A, D
E144S E142 W C, D
V145S V143 F, I
H172A H164 M M W W M F, I
R175A R167 M W W W W E, I
L183S L175 F, J
K185A K177 B, D
L186S A178 F, J
L187S L179 C, D
K189A K181 B, D
F190S L182 F, J
I193S L185 F, J
M200S M192 B, D
L201S L193 W W B, E
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Numbering Phenotypes Figure S3 Plate set
ScGet3 AfGet3
2mM Cu 
30°C
2mM Cu 
37°C
200mM 
HU 30°C
40°C overall
N202A N194 B, E
G206P G202 F, J
I212S L212 F, J
K215A K215 B, E
L216S M216 F, J
L219S L219 W M W G, J
E245A R245 W W W E, J
F246A F246 S S S S S E, J
L247S L247 M M M S S G, J
S248A S248 W M W S M G, J
Y250A Y250 S S S S S G, J
E251A E251 S S S S S G, J
E253A E253 S S S S S G, J
R254A R254 W E, J
Q257A Q257 W W W E, J
E258A E258 W M M M G, J
D265A D265 S S M S S B, E
C285T-
C288T
C283T-
C286T
S S S S S
C, D
R291A R289 S S S S S B, E
M294A M292 W W W W E, J
K297A K295 W W W W W E, J
Y298A Y296 M M S S S E, J
D300A E298 G, H
E320A E318 W M M M E, H
Y338A Y336 W W W W W B, E
G30 G38R M S M M M C, D
N/A R200A M M M G, H
Phenotypes in bold represent mutants that had been tested in previous studies. Mutants that could rescue 
knockout are unmarked. Mutants that could not fully rescue are shown by minus signs are graded by severity 
of growth defect: weak (W), moderate (M) and strong (S). Mutants that showed apparent gain of function are 
shown by plus signs (+).
Supplementary Table 2. Summary of  mutants
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C h a p t e r  2
TOWARD CRYSTALLIZATION OF A GET3 AND TAIL-ANCHORED PROTEIN 
COMPLEX
Introduction
Membrane protein localization is an essential process in the cell, and its importance is reflected 
in the universal conservation of the signal recognition particle (SRP) pathway for protein 
translocation (reviewed in Keenan et al., 2001; Shan and Walter, 2005). An important class of 
proteins is not accessible to the SRP pathway, however, due to their architecture. These tail-
anchored (TA) proteins have a single transmembrane domain close to the C-terminus 
preventing co-translational delivery (Kutay et al., 1993). TA proteins perform a diverse and 
critical set of functions as enzymes, protein transport and vesicle trafficking factors, apoptosis 
regulators and viral components (Beilharz et al., 2003; Kalbfleisch et al., 2007). The GET 
(Guided Entry of Tail-anchored proteins) pathway has been shown to post-translationally 
target TA proteins to the endoplasmic reticulum (ER) membrane (reviewed in Hegde and 
Keenan, 2011).
The first component of the GET pathway discovered was Get3 (TRC40 in mammals) and was 
shown to bind specifically to the transmembrane domain (TMD) of TA proteins (Stefanovic 
and Hegde, 2007; Favaloro et al., 2008). Next, a receptor complex of Get1 (WRB in mammals) 
and Get2 for Get3 in the ER membrane was found (Schuldiner et al., 2008; Vilardi et al., 
2011). This was followed by the discovery of a complex for sorting and loading TA proteins 
into Get3, Get4/5 and Sgt2 in S. cerevisiae and the Bag6 complex in mammals (Jonikas et al., 
2009; Chang et al., 2010; Costanzo et al., 2010; Leznicki et al., 2010; Mariappan et al., 2010). 
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Get3 is a homodimeric ATPase that functions as the central chaperone for receiving TA 
proteins from the sorting complex and delivering them to the membrane via the receptor.
Structural studies revealed that an open and closed state of Get3 is regulated by nucleotide 
(Bozkurt et al., 2009; Hu et al., 2009; Mateja et al., 2009; Suloway et al., 2009; Yamagata et al., 
2010). The apo and ADP bound forms are generally in the open state. In the ATP bound or 
transition state, Get3 undergoes conformational changes to form the closed state with 
movement in the relative orientation of the two subunits and rearrangement of helices distal 
to the nucleotide binding domain (Bozkurt et al., 2009; Mateja et al., 2009; Suloway et al., 
2009). Both of these movements cause a binding groove lined with conserved hydrophobic 
residues to form, which could accommodate the TMD of TA proteins (Bozkurt et al., 2009; 
Mateja et al., 2009). Mutagenesis of the hydrophobic binding groove by introducing polar or 
charged residues showed decreased binding of TA proteins to Get3 and reduced rescue of 
growth defects in S. cerevisiae Get3 knockouts (Mateja et al., 2009; Suloway et al., 2009). 
Disordered regions in the closed form crystal structures extend out from the helices vertically 
flanking the sides of the binding groove and have been proposed to shield the exposed 
portion of the binding groove. These regions are ordered in some open form structures 
through crystal contacts and have been shown to be essential for TA protein binding 
(Yamagata et al., 2010). They may play a more complex role than initially proposed.
The TMD of TA proteins varies in length and composition, and how Get3 accommodates or 
selects for these differences is a fundamental question about the function of the GET 
pathway. It has been suggested that positive charges on either end of the binding groove could 
reduce the propensity to bind longer mitochondrial TAs that are flanked by positive charge at 
the C-terminus (Borgese et al., 2007). How conformational change in Get3 induced by 
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nucleotide state and hydrolysis acts on the release of TA proteins is also a question. The 
structure of Get3 complexed with TA proteins would reveal the molecular mechanism for 
interaction of Get3 with TA proteins, give insight into the function of the GET pathway and 
be the basis for future studies.
The following chapter documents two techniques for forming a complex of Get3 with TA 
proteins for structural studies. First, recombinant co-expression of Get3 and TA proteins in E. 
coli produces milligram amounts of complex that can be purified. Second, in vitro 
reconstitution of the complex by combining solubilized TA protein with Get3 allows the 
addition of nucleotide and cofactors for formation of a complex in a controlled state. 
Structure determination by X-ray crystallography of recombinant complex was attempted 
with crystallization trials, crystal refinement and preliminary diffraction data to 11–12Å.
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Results
Cloning and Co-expression of  Get3 and TA Proteins
For this study our ultimate goal was to generate sufficient amounts of homogenous complex 
of Get3 with a TA protein for crystallographic structure studies. Generally, to efficiently 
achieve sufficient amounts of proteins for structural studies recombinant E. coli 
overexpression systems are used. TMDs are composed of a hydrophobic stretch of amino 
acids that normally reside in the membrane and are not part of the folded soluble portion of 
the protein. They are unprotected from the polar solvent unless shielded by chaperones until 
integrated into the membrane. Recombinant expression of TA proteins in E. coli would result 
in membrane integration, cytosolic aggregation or degradation. Overexpression could lead to 
overwhelming endogenous pathways for membrane integration leading to degradation or 
toxicity. Furthermore, TA proteins would have to be solubilized from the membrane or 
aggregates to form complex with Get3.
To avoid these complications and directly generate complex, Get3 was recombinantly co-
expressed in E. coli with the TA protein. Recombinant Get3 expressed in the cell would bind to 
TA proteins directly after synthesis or obtain them from endogenous chaperone mechanisms. 
In the absence of the Get1/2 receptor, complexes would remain intact for extraction and 
purification. To facilitate expression of different combinations of TA proteins and Get3 
constructs without additional cloning, TA proteins were cloned into a separate vector from 
Get3 constructs so the two plasmids could be co-transformed.
Tail-anchored proteins from previous bioinformatics surveys (Beilharz et al., 2003; Kalbfleisch 
et al., 2007) were selected for cloning to give a diversity in the N-terminal cytosolic domain, 
TA and C-terminal ER resident region. The region N-terminal to the TMD is longer than the 
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C-terminal region, which is often less than 10 amino acids, so tags for affinity purification 
were placed at the N-terminus of the TA-proteins to avoid disruption of TMD dependent 
complex formation and to ensure accessibility of the tag. S. cerevisiae and H. sapiens TA 
proteins were N-terminally His-tagged in the first MCS of the pACYCDuet vector. An N-
terminal MBP fusion to the TA protein Sbh1 separated by a thrombin protease cleavage site 
was cloned into the pMAL-C2 vector. The TA protein Sec61β was cloned into pET33b with 
an N-terminal FLAG tag. Table 1 provides a list of  cloned TA protein constructs.
For co-expression of Get3 and TA proteins an MBP fusion to Get3 in pMAL-C2 or an 
untagged Get3 construct in pET33b was co-transformed with His-tagged TA proteins in 
pACYCDuet into the E. coli expression strain BL21Gold. Co-transformations with MBP 
tagged Sbh1 in pMAL-C2 were carried out with a His-tagged Get3 or untagged Get3 in 
pACYCDuet. BL21Gold co-transformants were selected using the antibiotic resistant markers 
from both plasmids, grown at 37 C and induced for 3–4 h before harvesting. Expression of 
both Get3 and the TA proteins was typically strong enough to be seen by comparing the pre- 
and post-induction samples using SDS-PAGE (Supplemental Figure 1A).
Purification of  Get3 Complexed to TA Proteins
Complex purification from recombinant co-expression relies on the TA protein binding stably 
to Get3 in E. coli so that it can be extracted. Cultures induced for co-expression were pelleted, 
resuspended in lysis buffer and lysed. Cellular debris, including protein aggregates, were then 
pelleted and separated from the supernatant to yield a clarified extract. Stable complex 
formation present in the cell extract would remain soluble after centrifugation, and the 
presence of both the TA protein and Get3 could be confirmed by SDS-PAGE of the clarified 
extract (Figure 1A & B).
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To verify that TA protein was bound to Get3 instead of it being soluble on its own or 
chaperoned by an E. coli protein, a two-step affinity purification was performed using different 
affinity tags on the TA protein and Get3. In the first step of affinity purification of Get3 TA 
protein was present in elution fractions. For the second step affinity purification of the TA 
protein from the first step elution, unbound Get3 was washed away revealing only complex of 
Get3 and TA protein (Figure 1A). A one-step purification was also possible by affinity 
purification of only the TA protein as TA protein not bound to Get3 was insoluble, yielding 
only complex (Figure 1B).
Size-exclusion chromatography (SEC) was used for the final purification step for the complex 
and showed ScGet3 and the TA protein co-eluted in one peak, verifying complex formation 
(Figure 2). Interestingly, this peak corresponds to a dramatically shorter elution time indicating 
that even for small TA proteins the complex has a significantly larger hydrodynamic radius 
compared to Get3 alone. Complexed Get3 could be separated from uncomplexed Get3 as two 
separate peaks from SEC (Figure 2A). SDS-PAGE showed the first peak contains Get3 and 
TA protein whereas the second peak only contains Get3 (Figure 2B). Given the small size of 
TA proteins in the complex, it was likely Get3 exists in a higher oligomeric state than a dimer 
in the complex when recombinantly co-expressed and purified from E. coli.
Crystallization of  the Complex
Fractions collected from SEC corresponding to the peak with Get3 complexed with TA 
protein were used for crystallization trials. Complexes of ScGet3 with His-tagged Sbh1, Sbh2 
or Ysy6 were concentrated to 10–15mg/ml and dialyzed in crystallization buffer before use in 
crystallization screens. For initial screening commercial screens including the Crystal HT, 
Index HT, MembFac, PEG/Ion Screen, Wizard, PACT premier, and JCSG+ Suite were used.
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Most crystals appeared in screens for ScGet3 in complex with Sbh1 with the addition of 
ADP·AlFx, totaling 11 unique conditions. Crystals also appeared in one condition with the 
non-hydrolyzable ATP analog AMPPNP. Two conditions grew crystals for ScGet3 in complex 
with Sbh2 and one condition for complex with Ysy6, all with ADP·AlFx. Hits for Index H4, 
Wizard D6, PACT E1, Crystal D4, MembFac A3, Wizard C3 and PACT E11 were refined with 
a gradient around each of  the original conditions (Supplemental Figure 2).
In order to verify the crystals contained complex, they were subjected to SDS-PAGE. Three of 
the conditions with the largest single crystals (Figure 3A-C) had sufficient material for analysis 
and were removed from the drops, washed three times in the crystallization condition and 
resuspended in SDS-PAGE loading buffer. The samples were run on an SDS-PAGE gel and 
silver stained to detect Get3 and the TA-protein. Clear bands were visible at the molecular 
weight expected for Get3, but no TA protein bands were visible (Figure 3D). It is possible TA 
proteins are present but not in sufficient quantity (sub-microgram amounts of protein from 
the crystals) to be visible. The small size and hydrophobic nature of the TA proteins could also 
result in poor staining results.
Since the presence of complex in the crystals was unclear, X-ray diffraction data were 
collected using the crystals in hopes that the structure would reveal if TA protein was bound 
to Get3. Of the crystals that diffracted, the highest resolution diffraction spots were at 11Å for 
ScGet3 complexed with Ysy6 with MgADP·AlFx from the refined crystallization condition 
0.1M Sodium citrate and 20% PEG 3350, cryoprotected with 20% glycerol (Figure 3E). The 
best diffracting crystal from ScGet3 complexed with Sbh1 was in the same buffer as the Ysy6 
complex and was from the refined crystallization condition 0.1M Sodium citrate pH 6.2, 10% 
2-propanol and 20% PEG 4000. This crystal diffracted to 12Å when cryoprotected with 20% 
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glycerol. Due to the low resolution of the diffraction pattern no definitive indexing solutions 
could be found with iMosflm (Battye et al., 2011) for either crystal.
Alternative complexes of Get3 with TA proteins were tested. Co-expression of HsGet3/
TRC40 or AfGet3 with TA proteins failed to give a clean SEC profile. In an attempt to purify 
the complex in an ATP bound form, potentially ATPase inactive mutants of ScGet3 G27P, 
G28P, K31A,/R, D57I/K/L/V were co-expressed with Sbh1 and purified. G27P and D57L 
were selected for SEC, but G27P formed mostly aggregates and eluted in the void volume and 
D57L formed only small amounts of complex. Other TA protein substrates with larger and 
more complex N-terminal domains were tested but failed to elute in separable peaks (Table 2).
In vitro Complex Reconstitution
Crystals from conditions with ScGet3 complexed with TA proteins formed recombinantly 
failed to diffract to sufficient resolution for structure determination, and the presence of TA 
protein in the crystal could not be confirmed by SDS-PAGE. Since nucleotide state had been 
shown to be important for Get3 conformation (Bozkurt et al., 2009; Mateja et al., 2009), the 
presence of nucleotide was checked by measuring the magnesium concentration within the 
recombinant complex by inductively coupled plasma mass spectrometry (ICP-MS) (Yamagata 
et al., 2010). Although the concentration of zinc matched what would be expected to be 
coordinated by the CxxC motif of each dimer, the concentration of magnesium was 
approximately sixfold less (Table 3). Without the presence of magnesium it was unlikely there 
was nucleotide present in the complex. In previous crystallization trials magnesium and 
nucleotide analogs were added, but since bound TA protein could serve to stabilize the closed 
conformation of Get3, the nucleotide state was uncertain. Combining Get3 and the TA 
75
protein purified separately in vitro would allow the addition of nucleotide in a manner already 
shown to bind Get3 and possibly make a more stable and physiologically relevant complex.
Purifying the TA protein when expressed without Get3 requires it be made soluble by other 
means. One standard technique for solubilizing proteins is to use the denaturants urea or 
guanidine. The TA protein Ysy6 with an N-terminal His-tag was expressed in the E. coli 
expression strain BL21Gold. After centrifugation the pellet was resuspended in either urea or 
guanidine to lyse the cells and solubilize Ysy6, which was then affinity purified with Ni-NTA 
resin. Although concentration of urea from 1 to 8M solublized Ysy6, it could be pelleted by 
ultracentrifugation indicating it was forming large, partially soluble aggregates (Figure 4A). 
When 6M guanidine was used, Ysy6 remained in the supernatant after ultracentrifugation and 
thus accessible for complex formation (Figure 4B).
Using TA protein solubilized in denaturant to form complex without denaturing Get3 would 
eliminate the need to refold the entire complex bound to nucleotide at once. One technique to 
accomplish this would be to rapidly dilute the denatured TA protein into a buffer containing 
Get3, analogous to refolding proteins from denaturants. Ysy6 denatured in 6M guanidine was 
concentrated to ~175μM in 150μl and rapidly diluted into 15ml of ~30μM Get3 in TBS with 
either ADP, ATP, ADP·AlFx or without added nucleotide. This corresponds to a slight molar 
excess of Ysy6 to a Get3 dimer. After dilution the sample was ultracentrifuged to remove 
aggregates and added to NiNTA resin and then washed. Get3 complexed with Ysy6 was 
eluted with imidazole (Figure 4C). Elution fractions show complex formation in ATP and 
ADP·AlFx containing buffers but not for ADP. Surprisingly, the most complex was formed 
without nucleotide. The yield of complex was low with only microgram amounts of complex 
formed from more than 10mg of Get3. SEC was attempted for complex samples, but they 
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were not confidently detected by 280 or 214nm absorbance. Achieving milligram amounts of 
complex for crystallization trials by this would require further optimization of the protocol to 
reduce the amount of  purified Get3 needed.
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Figures
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Figure 1. Affinity purification of recombinant co-expression of ScGet3 complexed 
with TA proteins. (A) Two-step complex affinity purification analyzed by coomassie-stained 
SDS-PAGE. For the left gel the first two lanes are lysate and then supernatant after 
centrifugation. The next three lanes are the flow  though, wash and eluate from the first step 
of affinity purification using amylose resin for the MBP fusion to Get3. The final three lanes 
in the gel on the right are the flow  though, wash and eluate from the second step of affinity 
purification using Ni-NTA resin for the His-tagged TA protein Ysy6. Bands for MBP-
ScGet3 and 6xHis-Ysy6 are labelled. (B) One-step complex affinity purification analyzed by 
coomassie-stained SDS-PAGE. Similar to the left gel of (A) except the affinity purification 
used Ni-NTA resin for the His-tagged TA protein in complex with MBP-ScGet3. (C) 
Coomassie-stained SDS-PAGE purified complex of MBP-ScGet3 with three additional TA 
proteins: Sbh1, Tlg2 and Scs2. MBP-ScGet3 is labelled and asterisks indicate bands 
corresponding to the TA proteins.
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Figure 2. Size exclusion chromatography of ScGet3 complexed with TA protein. (A) A 
size-exclusion chromatograph of ScGet3 complexed with Sbh1 with the two prominent 
peaks labelled 1 and 2. (B) Coomassie stained SDS-PAGE of SEC fractions with lanes 1 and 
2 corresponding to peaks 1 and 2 in (A). The faster eluting peak 1 has a bands for both 
ScGet3 and Sbh1 (labelled) whereas peak 2 has a band for ScGet3 but not Sbh1.
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Figure 3. Crystals from conditions with Get3 complexed with TA proteins. (A) ScGet3 
complexed with Sbh1 in 0.2M ammonium citrate pH 7.0 and 20% PEG 3350. (B) ScGet3 
complexed with Sbh1 in 0.1M sodium citrate pH 5.6, 20% 2-propanol and 20% PEG 4000. 
(C) ScGet3 complexed with Ysy6 in 0.2M sodium citrate and 20% PEG 3350. (D) Silver-
stained SDS-PAGE of washed crystals from crystallization conditions with ScGet3 
complexed with TA proteins. Lanes 1–3 are from crystals in A–C. The arrow  indicates bands 
corresponding to ScGet3. (E) Diffraction image from ScGet3 complexed with Ysy6 with 
MgADP·AlFx in 0.1M Sodium citrate and 20% PEG 3350, cryoprotected with 20% glycerol. 
The edges of  the image corresponds to 11.5Å diffraction in the shortest dimension.
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Figure 4. In vitro reconstitution of Get3 complexed with TA protein. (A) Ysy6 affinity 
purified under denaturing conditions using urea. Stability was tested by ultracentrifugation 
with the pellet (lanes “P”) and supernatant (lanes “S”) analyzed by coomassie-stained SDS-
PAGE. In 8, 4, 2 and 1M urea Ysy6 was unstable and pelleted. (A) Ysy6 affinity purified 
under denaturing conditions using guanidine. As for (A) except the load (L) is shown for 
comparison to the supernatant (S) and Ysy6 remained stable in 6M guanidine with no visible 
band in the pellet (P). (C) Purification of in vitro reconstituted complex in different 
nucleotide states. Coomassie stained SDS-PAGE of apo, ADP, ATP and ADP·AlFx in vitro 
reconstitutions with fractions from the Ni-NTA affinity purification flow  through, washes 1 
& 2 and elutions 1–3. Get3 pulled down (band marked by an asterisk) as a complex with 
His-tagged Ysy6 (bands marked by arrowheads) in the elution fractions from apo, ATP and 
ADP·AlFx containing buffers.
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Protein Organism Construct Vector
Sec61β H. sapiens 6xHis-Sec61β (ΔTMD) pACYCDuet
Sec61β H. sapiens 6xHis-Sec61β pACYCDuet
Ysy6 S. cerevisiae 6xHis-Thr-Ysy6 (residues 37-65) pACYCDuet
Ysy6 S. cerevisiae 6xHis-Ysy6 pACYCDuet
RAMP4/SERP1 H. sapiens 6xHis-SERP1 pACYCDuet
Pex15 S. cerevisiae 6xHis-Pex15 pACYCDuet
Tlg2 S. cerevisiae 6xHis-Tlg2 pACYCDuet
Dpm1 S. cerevisiae 6xHis-TEV-Dpm1 pACYCDuet
Fis1 S. cerevisiae 6xHis-Fis1 pACYCDuet
Sed5 S. cerevisiae 6xHis-Sed5 pACYCDuet
Cyb5 H. sapiens 6xHis-Cyb5 pACYCDuet
Sbh1 S. cerevisiae 6xHis-Sbh1 pACYCDuet
Sbh1 S. cerevisiae 6xHis-6xArg-Sbh1 pACYCDuet
Sbh2 S. cerevisiae 6xHis-Sbh2 pACYCDuet
Scs2 S. cerevisiae 6xHis-Scs2 pACYCDuet
Mga2 S. cerevisiae 6xHis-Mga2 pACYCDuet
Mga2 S. cerevisiae 6xHis-Mga2 (ΔTMD) pACYCDuet
Sec22? S. cerevisiae 6xHis-Sec22 pACYCDuet
Sbh1 S. cerevisiae MBP-Thr-Sbh1 pMAL-C2
Sbh1 S. cerevisiae MBP-Thr-Sbh1 (residues 52-82) pMAL-C2
Sbh1 S. cerevisiae MBP-Thr-Sbh1 (residues 47-82) pMAL-C2
Sbh1 S. cerevisiae MBP-Thr-Sbh1 (residues 42-82) pMAL-C2
Sbh1 S. cerevisiae MBP-Thr-Sbh1-Thr-MBP (residues 47-82) pMAL-C2
Sec61β H. sapiens FLAG-Sec61β (ΔTMD) pET33b
Sec61β H. sapiens FLAG-Sec61β pET33b
Table 1. TA protein constructs cloned for co-expression
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Construct Expressed Co-expressed Affinity SEC Crystallized
6xHis-Sec61β (ΔTMD) +
6xHis-Sec61β + + + −
6xHis-Thr-Ysy6 (residues 37-65) + + −
6xHis-Ysy6 + + + + +
6xHis-SERP1 +
6xHis-Pex15 + + + −
6xHis-Tlg2 + + + −
6xHis-TEV-Dpm1 + −
6xHis-Fis1 + +
6xHis-Sed5 +
6xHis-Cyb5 + + −
6xHis-Sbh1 + + + + +
6xHis-6xArg-Sbh1 + + + +
6xHis-Sbh2 + + + + +
6xHis-Scs2 + + −
6xHis-Mga2 + −
6xHis-Mga2 (ΔTMD) +
6xHis-Sec22 +
MBP-Thr-Sbh1 + + + + −
MBP-Thr-Sbh1 (residues 52-82) + + + +
MBP-Thr-Sbh1 (residues 47-82) + + + + −
MBP-Thr-Sbh1 (residues 42-82) + + + +
MBP-Thr-Sbh1-Thr-MBP 
(residues 47-82) +
FLAG-Sec61β (ΔTMD) +
FLAG-Sec61β +
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Table 2. Per substrate complex formation and purification with ScGet3 Constructs 
correspond to Table 1. Plus signs indicate successful completion of the step, minus signs 
indicate unsuccessful attempts and blank entries have not been tested. Co-expression was 
performed with ScGet3.
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Component Measured concentration Molar concentration Expected concentration
Get3/Sbh1 561 mg/L 6.79 μM N/A
Mg(H2) 51 μg/L 1.94 μM 13.59 μM
Zn 370 μg/L 5.66 μM 6.79 μM
Table 3. Co-factors in Get3 complex with TA proteins by ICP-MS. Each component 
has a measured concentration, Get3/Sbh1 by 280nm absorbance and Mg(H2)/Zn by ICP-
MS. The molar concentration is calculated based on the estimated molecular weight. The 
expected concentration is calculated by the molar concentration of Get3/Sbh1 with two 
magnesium and one zinc ions per Get3 dimer.
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Discussion
Since the identification of Get3/TRC40 (Stefanovic and Hegde, 2007; Favaloro et al., 2008) as 
a novel targeting factor for TA proteins, a number of structural studies have provided 
information on the molecular mechanisms for its function (Bozkurt et al., 2009; Hu et al., 
2009; Mateja et al., 2009; Suloway et al., 2009; Yamagata et al., 2010). Yet there is still no direct 
structural evidence for how Get3 interacts with TA proteins and how this is coupled to the 
targeting process. This work demonstrates two methods for generating a complex of Get3 
with TA proteins and preliminary work for X-ray structure determination of the complex. 
Recombinant co-expression of Get3 with TA proteins in E. coli yields complex that can be 
purified in sufficient quantity for crystallization. In vitro reconstitution is capable of forming 
complex in the presence of nucleotide and with refinement could be used for structural 
studies. A number of crystal hits from co-expressed complex yielded low resolution 
diffraction, and future studies could improve diffraction in order to solve the structure of 
Get3 in complex with TA protein.
TA proteins perform a range of functions including enzymatic activity, protein transport, 
vesicle trafficking, apoptosis regulation and viral infectivity. This diversity is reflected in the size 
and structure of their N-terminal cytosolic domains. The length and composition of the TA 
and C-terminal region varies as well. There are a number of possible TA proteins and 
constructs to test for co-crystallization with Get3. A minimal binding construct could reduce 
disorder and flexibility whereas an ordered N-terminal domain could stabilize lattice 
formation. Using a range of different TA proteins for complex crystallization improves the 
chances of  finding crystallization hits for structure determination.
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In order to facilitate rapid screening of complexes, a co-expression system was employed using 
two plasmids, one encoding a Get3 construct and another with a TA protein. Get3 was 
successfully co-expressed with a variety of TA proteins. The purification procedure used 
different affinity tags on Get3 and the TA proteins and a two-step affinity purification to 
ensure a resulting homogenous complex. As expected for a complex, purified Get3 and TA 
protein co-eluted in SEC in a single peak, but it should be noted a sizable peak of 
uncomplexed Get3 was also observed. These two peaks were easily distinguishable due to the 
complex eluting much sooner than expected for a Get3 dimer, even with relatively small TA 
proteins. One explanation is that the complex of Get3 with TA proteins contains a higher 
oligomeric state of  Get3 than a dimer.
Purified Get3 TA complex with Sbh1, Sbh2 and Ysy6 were used in crystallization trials. 
Nucleotide analogs AMPPNP and ADP·AlFx were added to stabilize the closed form of the 
dimer that had been proposed for the TA bound state of Get3. Crystals grew in many unique 
crystallization conditions with a variety of morphologies. The crystals fluoresced under UV 
illumination indicating they were protein crystals, unless the additives for ADP·AlFx 
fluoresced as well. Crystallization hits were refined and conditions that formed the largest 
single crystals were selected for further analysis. The crystals were analyzed by SDS-PAGE for 
the presence of TA protein, but this could not be confirmed. One possibility is that there was 
insufficient TA protein for detection or there was less detection sensitivity for small 
hydrophobic proteins. Another explanation would be the dissociation of the complex that 
could be exacerbated by particular crystallization conditions. Since Get3 readily crystallizes, 
even small amounts of uncomplexed Get3 could form crystals or there could be bias toward 
conditions that dissociate the complex. More sensitive detection techniques might reveal the 
presence of  TA proteins in the crystals.
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Crystals diffracted X-rays to a resolution of 11–12Å, which was insufficient for structure 
determination. Disorder caused by the flexible N-terminal regions of the TA-proteins could 
lower the resolution of diffraction. Sbh1 and Ysy6 have small but not insignificant N-terminal 
domains, and a minimal TA protein construct for complex formation could reduce the 
disorder in the crystal. Hydrophobic interactions can be nonspecific and different 
conformations of complex could arise from the same substrate causing heterogeneity and 
reducing order in the lattice. Similarly, different stoichometry of TA proteins bound to Get3 
could have slightly different conformations that could cause disorder and result in low 
resolution diffraction. Many of the more general techniques for crystal improvement could be 
applied as well (Bergfors, 2003; Heras and Martin, 2005; Derewenda and Vekilov, 2006).
Different methods for complex generation might yield a more crystallographically amenable 
and physiologically relevant complex than recombinant co-expression in E. coli. The apparent 
lack of nucleotide in the recombinant complex is of concern. Structural studies have shown 
the presence of nucleotide modulates the conformation between an open and closed form. 
The closed form presents a hydrophobic groove that is a putative binding site for TA proteins, 
and this conformation could be necessary for stable complex formation. Generally, protein 
complexes of soluble proteins can be made in vitro by simply combining the component 
proteins, which allows for manipulations such as co-factor addition, including nucleotides. TA 
proteins are hydrophobic making them unstable in solution so accommodations must be made 
to apply this method to forming complex with Get3. Denaturants were used to solubilize TA 
proteins and rapid dilution into a buffer containing Get3 resulted in complex formation. 
Interestingly, the apo, ATP and ADP·AlFx states formed complex, but the ADP state did not. 
Since the apo state is open and the ADP·AlFx state is closed, presumably either state can form 
complex. The apo state could close upon TA binding. The ATP bound state should be closed 
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before hydrolysis, but even if ATP was hydrolyzed it has been suggested that Pi does not 
dissociate immediately from Get3 and could remain in the closed state (Bozkurt et al., 2009). 
Why Get3 cannot form complex when ADP is bound remains an interesting question. 
Ultimately the yield from in vitro reconstitution was too low for structural analysis of the 
complex.
For S. cerevisiae the in vivo process of loading TA proteins into Get3 involves many additional 
protein factors including chaperones, Sgt2, Get4 and Get5 (Wang et al., 2010). This 
mechanism could serve to sort ER TA proteins appropriate for Get3 from other proteins as 
well as load TA proteins into Get3 to form a complex competent for insertion. When co-
expressing Get3 with TA proteins recombinantly, these factors are absent so it is somewhat 
surprising the complex forms at all. Recombinant complex is functional as it inserts TA 
proteins into ER derived microsomes in an in vitro reaction (Favaloro et al., 2008; Bozkurt et 
al., 2009; Favaloro et al., 2010). Nonetheless, whether recombinant or in vitro reconstituted 
complex represents the physiological state remains a question, especially considering 
recombinant complex might represent a higher oligomeric state of  Get3 than a dimer.
The structure of Get3 complexed with TA proteins would give much-needed insight into the 
molecular mechanisms of the GET pathway. Two methods for generating a complex of Get3 
with TA proteins have been presented here. Recombinant co-expression of Get3 with a TA 
protein in E. coli is capable of forming a complex with a number of different TA proteins. In 
vitro reconstitution of complex from purified Get3 and denatured TA proteins allows for 
complex formation in different nucleotide states. Crystals formed from crystallization trials of 
the complex and could be refined, although the presence of TA proteins is unconfirmed. 
More work is needed to improve the diffraction of these crystals to be able to determine the 
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structure with X-ray crystallography. How Get3 interacts with TA proteins and what role the 
mechanism plays in the GET pathway are important questions about the process of protein 
translocation.
92
Materials and Methods
Cloning
S. cerevisiae TA proteins were amplified from S288c (ATCC) genomic DNA except for Ysy6 
constructs which were synthesized from primers designed with DNAWorks (Hoover and 
Lubkowski, 2002). H. sapiens TA proteins were all primer synthesized using DNAworks. N-
terminally 6xHis-tagged TA proteins Ysy6, SERP1, Fis1, Sed5, Cyb5, Sbh1, Sbh2, MGA2, 
MGA2 residues 2-1036 and Sec22 were cloned into the first MCS of pACYCDuet (Novagen) 
using restriction sites for BamHI and PstI. Pex15, Tlg2 and Scs2 were cloned using HindIII 
instead of PstI due to an internal PstI site. Ysy6 residues 37-65 were synthesized with an N-
terminal 6xHis-tag and thrombin protease cleavage site and were cloned into pACYCDuet 
with NcoI and PstI restriction sites. N-terminally 6xHis-tagged Dpm1 with a TEV protease 
restriction site was subcloned from a previous construct in pET33b (Novagen) using NcoI 
and NotI restriction sites. N-terminally FLAG tagged Sec61β  and Sec61β  residues 2–69 were 
primer synthesized using DNAWorks and cloned into pET33b using NcoI and BglII 
restriction sites. Both constructs were subcloned into pACYCDuet into SalI and NotI 
restriction sites to for N-terminally 6xHis-tagged constructs. N-terminal MBP fusions to 
Sbh1 with a thrombin protease cleavage site in pMAL-C2 (NEB) were created by first using 
site-directed mutagenesis to change the factor Xa cleavage to a thrombin cleavage site and 
then cloning PCR amplified Sbh1 into BamHI and PstI sites to account for a frame shift from 
the pACYCDuet vector BamHI site. N-terminally 6xHis-6xArg-tagged Sbh1 was made by site-
directed mutagenesis (Stratagene) of the 6xHis-tagged Sbh1 pACYCDuet construct. 
Truncations of Sbh1 with an N-terminal MBP fusion in pMAL-C2 were also made by site-
directed mutagenesis.
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N-terminally 6xHis-tagged ScGet3 and AfGet3 with a thrombin protease cleavage site in 
pET33b from a previous study were used (Suloway et al., 2009). HsGet3/TRC40 was 
amplified from the cDNA clone in pCMV-XL6 (OriGene) and cloned in pET33b using SalI 
and BglII restrictions to make a thrombin cleavable N-terminally 6xHis-tagged construct. 
Untagged ScGet3 in pACYCDuet was amplified from the 6xHis-Thr-ScGet3 pET33b 
construct and cloned used NcoI and XhoI restriction sites. Untagged S. cerevisiae Get3 in 
pET33b was subcloned from pACYCDuet using the same restriction sites. N-terminal MBP 
fusions to ScGet3 and AfGet3 with a thrombin protease cleavage site in pMAL-C2 were 
cloned into the MBP-Thr-Sbh1 contruct using XbaI and PstI restriction sites to replace Sbh1. 
HsGet3/TRC40 was cloned into the MBP-Thr-ScGet3 construct with XbaI and EcoRI 
(replacing the ScGet3) to avoid an internal PstI restriction site.
Co-expression
BL21Gold(DE3) cells (Stratagene) were co-transformed with various Get3 constructs and TA 
proteins as follows: His-tagged TA proteins (pACYCDuet) co-transformed with MBP-Thr-
Get3 (pMAL-C2) or untagged Get3 (pET33b) and MBP-tagged TA proteins (pMAL-C2) co-
transformed with His-tagged or untagged Get3 (pACYCDuet). Co-transformants were 
selected with antibiotic resistant markers from both plasmids, inoculated into 2×YT medium 
cultures and grown at 37°C. Once the cultures reached an OD600 of 0.6–0.8 they were 
induced with 0.3mM IPTG an allowed to express for 3–4h at 37°C. Cells were harvested by 
centrifugation at 6000g for 20m at 4°C.
Purification
Cells were resuspended in 10ml lysis buffer (50mM Tris pH 7.5, 300mM NaCl, 10mM βME 
and 0.1mM PMSF) per 1g cells using a Dounce homogenizer and lysed by 2–3 passes though 
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a ML-110L microfluidizer (Microfluidics). Cell debris was pelleted at 45000rpm in a Ti45 rotor 
for 30m at 4°C using an Optima L-80 XP ultracentrifuge (Beckman Coulter). The supernatant 
was applied to either Ni-NTA resin (Qiagen) or amylose resin (NEB) for 1-2h at 4°C. The 
resin was washed with 50mM Tris pH 7.5, 300mM NaCl, 10mM βME (10mM imidazole when 
using Ni-NTA resin) and eluted with the same buffer containing 200mM imidazole or 10mM 
maltose for Ni-NTA and amylose resins, respectively. If thrombin was used for cleavage, 2U 
thrombin per ml of eluate was added and incubated for 12-16h at room temperature. When a 
second affinity purification step was used, the same protocol for the first step was followed 
but for the other affinity tag. Purified protein was concentration for injection on a Superdex 
200 10/300 or 16/60 size-exclusion column (GE Healthcare) and run in 10mM Tris pH 7.5, 
100mM NaCl and 10mM βME. Fractions were analyzed by SDS-PAGE for the presence of 
complex, pooled and concentrated to 10-15 mg/ml for crystallization trials.
Crystallization and X-ray Diffraction
ScGet3 complexed with Sbh1, Sbh2 or Ysy6 was diaylzed in 10mM Tris pH 7 and 10mM 
βME for ADP·AlFx reactions, and 2mM MgCl2, 2mM ADP, 2mM AlCl3 and 8mM NaF were 
added and incubated at room temperature for 1h. Complex used in AMPPNP reactions was 
dialyzed in 10mM HEPES pH 8 and 10mM βME before addition of 2mM MgCl2 and 2mM 
AMPPNP. Crystallization with the Crystal (Hampton), Index (Hampton), PEG/Ion 
(Hampton), MembFac (Hampton), PACT (Molecular Dimensions), JCSG+ (Qiagen) and 
Wizard (Emerald BioSystems) screens by sitting drop vapor diffusion were setup with equal 
volumes of protein and well solution (either 0.1μl or 0.2μl each) in MRC 2-well crystallization 
plates (Swissci) by a Mosquito liquid handling robot (TTP LabTech) at room temperature. 
Crystal hits were refined with a gradient of each component around the initial condition with 
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0.4, 1 or 2μl drops. Crystals from refined conditions (see Results section) were transferred to 
an artificial mother liquor containing either MgADP·AlFx or MgAMPPNP and 20% glycerol 
or ethylene glycol (EG) for 5m, or they were soaked for 5m in 0, 5, 10 and then 20% glycerol 
or EG. Cryoprotected crystals were then flash frozen in liquid nitrogen and diffracted at 100K 
at the Stanford Synchrotron Radiation Lightsource, beam line 12-2, in the SLAC National 
Accelerator Laboratory. Diffraction data were collected using Blu-Ice (McPhillips et al., 2002) 
and analyzed with iMosflm (Battye et al., 2011).
In vitro Reconstitution
TA proteins for in vitro reconstitution were transformed into BL21Gold(DE3) cells, 
inoculated into 2×YT medium culture, grown to an at 37°C to an OD600 of 0.6-0.8, induced 
with 0.3mM IPTG for for 3-4h at 37°C. Cells were harvested by centrifugation at 6000g for 
20m at 4°C. Cell pellets were lysed with 50mM Tris-Cl, 5mM imidazole and either 8M urea or 
6M guanidine HCl pH 7.5 at room temperature and spun down at 10000g for 30min. The 
supernatant was incubated on Ni-NTA resin for 1h, washed with the same buffer and eluted 
with buffer containing 200mM imidazole. Ultracentrifugation of samples was done at 60000g 
for 18m at 20C using a TLA 100.3 rotor in an Optima MAX-E ultracentrifuge (Beckman 
Coulter). Reconstitution by rapid dilution was performed by adding 150μl denatured TA 
protein drop-wise to 15ml of a stirred dilution buffer of 50mM Tris-Cl pH 7.5, 300mM NaCl, 
4mM MgCl2 and 10mM βME and a 1:100 or 1:2 molar ratio of Get3 to added TA protein. 
Nucleotides were added to the buffer as 5mM ADP (ADP), 5mM ATP (ATP) or 5mM ADP, 
5mM AlCl3 and 8mM NaF (ADP ·AlFx). Complex was recovered by incubation with 100μl of 
Ni-NTA, washing twice with 500μl of dilution buffer with 10mM imidazole added and then 
eluting three times with 100μl of  a dilution buffer with 250mM imidazole added.
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Supplementary Figures
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Supplementary Figure 1. Recombinant co-expression and affinity purification of 
ScGet3 complexed with TA proteins. (A) SDS-PAGE (coomassie-stained) of pre- and 
post-induction samples of an MBP fusion to ScGet3 co-expressed with His-tagged TA 
proteins: Sec61β, Sec61β  ΔTMD, Pex15, Fis1, SERP1 and Sbh1. The first lane is the pre-
induction sample and the second is the post-induction sample, repeated for each TA protein. 
The position of Get3 is labelled and asterisks indicate bands corresponding to the expressed 
TA protein. Pex15, a peroxisomal protein, fails to express and the bands for Sbh1 are 
ambiguous as denoted by a question mark. Sec61β, Sec61β  ΔTMD, Fis1, SERP1 express 
clearly in the post-induction samples. (B) SDS-PAGE (coomassie-stained) of affinity 
purification steps of Get3 complexed with TA-protein. Co-expressed complex was affinity 
purified for the His-tagged TA protein with Ni-NTA resin. Complex is retained for all 
expressed samples except the mitochondrial TA protein Fis1 which is insoluble and Sec61β 
ΔTMD, both negative controls for specific TA protein binding to Get3.
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Supplemental Figure 2. Crystals from initial screens of ScGet3 complexed with TA 
proteins. The condition lists the complex and nucleotide used followed by the composition 
of the condition and the screen and location it originated from. Images from visible and UV 
illumination of the crystals from the listed condition under a microscope is shown on the 
right.
101
C h a p t e r  3
TAIL-ANCHORED PROTEIN TARGETING BY A GET3 TETRAMER
Introduction
Targeted delivery of membrane proteins is a highly regulated process. The ubiquitous co-
translational signal recognition particle (SRP) pathway is responsible for the delivery of the 
majority of membrane proteins (Shan and Walter, 2005). Tail-anchored (TA) membrane 
proteins are exceptions. They are defined topologically as having a single transmembrane 
domain (TM) near their C-terminus (Borgese, 2003). Found in cytoplasmically associated 
membranes of all organisms, they account for 2–3% of open reading frames in humans and 
nearly 1% in yeast and prokaryotes (Beilharz et al., 2003; Kalbfleisch et al., 2007; 
Kriechbaumer et al., 2009; Pedrazzini, 2009; Borgese and Righi, 2010). The signal for TA 
protein membrane delivery, the C-terminal TM, is not accessible for targeting by the SRP 
pathway (Kutay et al., 1993); therefore, they must be delivered via a different route. 
In eukaryotes, pathways for TA protein delivery to the ER have recently been elucidated 
(reviewed in Rabu et al., 2009; Simpson et al., 2010). The majority of TA proteins are targeted 
via the GET pathway (Guided Entry of TA proteins). This pathway, here described for yeast, 
progresses from a Sgt2/Get4/Get5 sorting complex (Bag6 complex in mammals (Mariappan 
et al., 2010)) that delivers an appropriate TA protein to the ATPase Get3 (TRC40 in mammals) 
(Battle et al., 2010; Chartron et al., 2010; Wang et al., 2010), which then targets the protein to 
the ER membrane via Get1/Get2 (Schuldiner et al., 2008). The central protein Get3 was the 
first component discovered that directly participates in TA-targeting (Stefanovic and Hegde, 
2007). Get3 binds specifically to the TM of a TA-substrate and is essential for efficient 
delivery to the ER (Stefanovic and Hegde, 2007; Favaloro et al., 2008; Schuldiner et al., 2008). 
102
Based on structural studies, a functional model for Get3 has been proposed where nucleotide 
state modulates an ‘open’ versus ‘closed’ homo-dimer (Bozkurt et al., 2009; Hu et al., 2009; 
Mateja et al., 2009; Suloway et al., 2009; Yamagata et al., 2010). As proposed, the ‘closed’ dimer 
uses a helical sub-domain (HSD) to form a hydrophobic groove for binding the TM of the 
TA protein. However, biochemical studies in mammalian extracts showed that TA proteins 
form complexes with Get3 compatible with a higher order complex (Stefanovic and Hegde, 
2007; Favaloro et al., 2008). Furthermore, recombinant expression of Get3 with a TA-
substrate yields a complex capable of TA membrane insertion in vitro. In this case, the 
complex contains a Get3 tetramer suggesting this is the oligomeric state of the targeting 
complex (Bozkurt et al., 2009; Favaloro et al., 2010). The difference between the dimer and 
tetramer models suggested by either structure or biochemistry remain to be reconciled.
A homologue of Get3 was recently identified in archaea that had previously been annotated 
as an ArsA, a structurally related bacterial ATPase involved in arsenate export (Borgese and 
Righi, 2010). Based on homology alone, distinguishing an ArsA from a Get3 is difficult; 
however, several key differences have been identified. The simplest is that Get3 is a homo-
dimer while the ArsA monomer contains a tandem repeat, forming a pseudo-dimer. Get3 lacks 
the identified metal coordinating residues of ArsA (Boskovic et al., 1996; Stefanovic and 
Hegde, 2007) but contains a unique “Get3 motif ” that is required for TA-binding (Mateja et 
al., 2009) (Figure S1). Additionally, Get3 homologues typically contain a pair of cysteines at 
their dimer interface that coordinate zinc and are essential for function (CxxC motif) (Metz et 
al., 2006; Stefanovic and Hegde, 2007). 
The need for a specific TA-targeting protein, such as Get3, was thought to be unique to 
eukaryotes that contain membrane bound organelles and, thereby, multiple membranes for 
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insertion. The presumption has been that in prokaryotes there is no specialized machinery for 
delivery of TA proteins, as they would not require targeting to a specific membrane, indeed 
none have been found in eubacteria. The identification of a Get3 homologue in archaea brings 
this idea into question. Of the currently sequenced archaeal genomes roughly 50% contain a 
putative Get3. These can be classified into two groups based on the presence of the CxxC 
motif. They are found in methanogens, halophiles and thermophiles implying that organisms 
in these extreme environments have an additional level of  complexity in membrane insertion.
Here we present the first structure of an archaeal Get3 from Methanocaldococcus jannaschii 
(MjGet3). The structure is of a symmetrical homo-tetramer and features a hydrophobic 
chamber that we postulate sequesters the hydrophobic TA. We demonstrate that the archaeal 
Get3 is capable of TA binding, that the solution state of a fungal Get3/TA complex is similar 
to the tetrameric MjGet3 and this fungal tetramer complex is capable of membrane insertion. 
This allows us to postulate a new model for TA-targeting by Get3.
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Results
Structure of  MjGet3
MjGet3 was purified and crystallized after recombinant expression in E. coli. We noted that the 
protein appeared to be a tetramer by size exclusion chromatography (SEC), further discussed 
below. The best crystals grew in the presence of ADP or the nucleotide analog ADP•AlFx in 
two space groups. The two crystal forms were P2 diffracting to 3.2Å and P21 diffracting to 
3.3Å grown in ADP and ADP•AlFx respectively. Both structures were solved by molecular 
replacement, the P21 structure using a nucleotide-hydrolase domain (NHD) from AfGet3 
(3IBG) as the search model and the P2 structure using a NHD from the P21 structure. The 
remainders of both structures were built independently. The final refined structures had free 
R-factors of 29.6% for the P2 and 28.2% for the P21 forms. Data collection statistics are 
presented in Table S1. The two structures are very similar with an RMSD of 0.8Å over all Cα. 
There are four copies of MjGet3 in the asymmetric units forming a homo-tetramer (Figure 1A 
& B, S2). The overall structure results in a dumbbell shaped particle approximately 150Å long. 
Unless noted, all figures will use the structure from the P21 crystal form.
Individual subunits of MjGet3 are very similar to those from fungal Get3 structures (Figure 
1C and S3). They closely align in the NHD with an RMSD of 0.8Å for residues 24-96, 
149-171 and 234-333 of MjGet3 to the transition state ‘closed’ ScGet3 (2WOJ). There is clear 
density for ADP and a magnesium ion; however, at this resolution we could not clearly resolve 
the presence of an AlFx in the P21 form (Figure 1D). There are a number of features of the 
NHD including switch I and II loops, which are responsible for transmitting changes in the 
nucleotide state to conformational changes related to function (Sprang, 1997; Leipe et al., 
2002). For Get3, it has been suggested that they play a role in modulating between the open 
and closed state of Get3 as a dimer (Bozkurt et al., 2009; Mateja et al., 2009; Suloway et al., 
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2009). Here, the switch I region is similar in conformation to structures of ‘closed’ fungal 
Get3 (Figure 1C and S3). Switch II is connected to helix 7. This helix has moved away from 
the NHD to form the tetramer cage pulling the switch II loop into a conformation not 
compatible with hydrolysis (Figure 1D and S4A & B). The organization of this region is 
closer to the conformation of the structure of the ‘closed’ fungal Get3 bound to ADP 
(3IQX) (Figure S3).
As seen before, two of the monomers come together to form a dimer stabilized by a cysteine-
coordinated zinc (Figure 1A & B). There are two of these dimers in each tetramer. The 
structures are very similar and were partially constrained by non-crystallographic symmetry 
during refinement. The orientations of the monomers in the dimer are most consistent with 
the transition state ‘closed’ form of  ScGet3 (Figure 1E & F and S3). 
The most dramatic difference between tetrameric MjGet3 and the dimeric ‘closed’ ScGet3 are 
the helices that surround the putative TA binding groove (Figure 1E & F). Helix 6, which lies 
at the base of the groove, matches the conformation of the transition state ‘closed’ ScGet3 
(2WOJ), tilted relative to other fungal structures. Helix 6 is shorter in the MjGet3 tetramer 
than in the ScGet3 dimer and has moved in the direction of the dimer interface. This shortens 
the proposed hydrophobic binding groove by ~10Å (Figure S3) (Mateja et al., 2009). The end 
of helix 6 becomes more exposed relative to the ‘open’ form (2WOO) (Figure S3) consistent 
with hydrogen/deuterium exchange experiments that show this helix exchanges hydrogen 
more rapidly after TA binding (Bozkurt et al., 2009). The five helices flanking the groove 
(helices 4,5 and 7,8,9) are in a similar orientation to that seen in the ‘closed’ fungal structures 
(Figure 1E & F). They are extended and more ordered, with only eight residues connecting 
helix 8 to helix 9 missing backbone density. 
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Instead of a hydrophobic binding groove, the MjGet3 tetramer uses the flanking helices to 
form the walls of a cage generating a hydrophobic central chamber (Figure 1A & B). Here, 
and in closed fungal Get3 structures, the loop formed by helices 4 and 5 (4/5 loop) is on the 
opposite side of helix 6 from the loop formed by helices 7 through 9 (7/8/9 loop) (Figure 
1C). In MjGet3 the 4/5 loop tilts away from the binding groove. In doing so it forms a three-
helix bundle to helix 8 extended from a subunit across the tetramer stabilized by hydrophobic 
interactions (Figure 1A & B). Calculated by PISA (Krissinel and Henrick, 2007), the tetramer 
buries an additional ~6000 Å2 relative to the dimers (~11,000 Å2) with the three-helix bundle 
providing most of  the contacts. 
The chamber formed by the tetramer is predominantly hydrophobic (Figure 2A). The size of 
the internal cavity is ~30Å across the middle to ~40Å down the long axis (Figure S5). This is 
compatible with the dimensions of a single TM with volume remaining for additional helices. 
The chamber is lined by helices 5, 7, 8 & 9. Unlike in the dimer model, helix 4 is on the 
periphery as part of the three-helix bundle (Figure 2B). The two helix 8s from the dimer 
extends into the groove of the opposing dimer (Figure 2B). The result is that they cover the 
floor and block the ends of the groove. This configuration prevents direct contact from helix 
6 to the chamber. The cage has openings at the site where the disordered loop between helix 8 
and 9 is missing (Figure 2C), which could provide an access point between the internal 
chamber and the cytoplasm. This opening, when viewed based on electrostatic potential, has 
an overall positive charge. The general charge is conserved in eukaryotes and is consistent 
with a discrimination point preventing binding of mitochondrial TA proteins (Mateja et al., 
2009).
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Extensive mutagenesis has been performed on ScGet3 by our lab and others (Figure 2D and 
S6) (Mateja et al., 2009; Suloway et al., 2009). Mateja et al. focused on the putative TA-binding 
groove and identified three classes of mutations: those that affect TA-binding (blue), 
nucleotide hydrolysis (red) or both (purple). The location of residues that affect nucleotide 
hydrolysis predominantly cluster to the base of the groove on helix 6; however, in the dimer 
model these residues did not affect TA-binding despite being components of the putative 
groove. In the tetramer structure, the reason for this becomes clear as these residues do not 
directly contact the hydrophobic chamber and, therefore, would not be predicted to affect 
binding (Figure S6B & C). They do lie directly below the chamber and would be expected to 
communicate the state of the chamber to the NHD. The mutants that affect TA-binding all 
coat the interior of  the hydrophobic chamber (Figure 2D & S6C).
Archaeal Get3 Binds Tail-anchored Proteins
The high sequence and structural homology between fungal and archaeal Get3 suggests that 
the archaeal protein is capable of binding TA proteins. We established a method for purifying 
a Get3/TA protein complex heterologously in E. coli using a two-step purification procedure 
where both Get3 and the TA protein contain affinity tags (Figure 3A) (similar to (Bozkurt et 
al., 2009; Favaloro et al., 2010; Yamagata et al., 2010)). Using this method we could reliably 
purify ScGet3 bound to a variety of TA-substrates. We analyzed the complex using inductively 
coupled plasma mass spectrometry (ICP-MS) to identify bound ions (Yamagata et al., 2010). 
We found an approximate 2:1 ratio of Get3 to zinc but only trace amounts of magnesium 
suggesting that there are no appreciable amounts of bound nucleotide, consistent with what 
has been reported before. An example of this complex is the purification of ScGet3 bound to 
Sbh1, the yeast homologue of mammalian Sec61β  and a demonstrated GET pathway 
substrate (Figure 3B, lane 1) (Schuldiner et al., 2008). Interestingly, when we co-expressed 
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MjGet3 with Sbh1 we were able to purify a stable chimeric complex confirming that the 
archaeal homologue is capable of binding a TA protein (Figure 3B, lane 2). As a control, co-
expression of MjGet3 with a TM deletion of Sbh1 was unable to form a complex by this 
method demonstrating that MjGet3 specifically bound the TA (Figure S7A & B).
Next, we tested to see if the archaeal Get3 was capable of binding a native substrate. We first 
co-expressed MjGet3 with MjSecβ, the archaeal homologue of Sec61β  whose structure has 
been solved and is predicted to be a TA protein (Van Den Berg et al., 2004; Borgese and Righi, 
2010). Using our two-step purification, we were able to obtain a stable complex of the two 
proteins (Figure 3B, lane 3). Neither component was recovered when expressed alone and 
purified by the same two-step procedure.
A number of additional TA proteins have been identified bioinformatically from Methanococcus 
maripaludis, a related species to M. jannaschii (Borgese and Righi, 2010). Some of these have 
homologs in M. jannaschii including SecE, another Sec channel component and MtrA and 
MtrB, TA-subunits of tetrahydromethanopterin S-methyltransferase. All three proteins could 
be purified as a complex bound to MjGet3 (Figure 3B, lane 4-6). We wanted to test another 
archaeal homologue and chose to work with the Get3 from Thermococcus kodakaraensis 
(TkGet3). This Get3 falls into the class of archaeal homologues missing the pair of zinc-
coordinating cysteines. Using the two-step method, TkGet3 is capable of forming stable 
complexes with the same set of  TA proteins tested for MjGet3 (Figure 3B, lanes 7-11). 
The binding chamber only sequesters the TM
Get3 specifically recognizes and binds the hydrophobic TA (Stefanovic and Hegde, 2007). The 
nature of the tetramer’s hydrophobic chamber suggests it is capable of sequestering a TA; 
however, it would be unable to fit a typical soluble domain. We would postulate that while the 
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TA is in the chamber the soluble domain extends out through the gap in the cage. The 
consequence would be that Get3 would only protect a minimal amount of the TA protein 
from solvent. Our double affinity tagged system provides a means to test this. Here, we took 
the N-terminal fusion of MBP to Sbh1 and introduced a thrombin protease site between the 
two proteins, which we then co-expressed with ScGet3 and purified (Figure 3A & C). For the 
full-length MBP-Sbh1 fusion, the addition of thrombin resulted in a gel shift of MBP from 
running as a fusion to MBP alone (Figure 3D, lane 1 versus lane 2). TM topology predicting 
software, TMHMM 2.0 (Krogh et al., 2001), predicts the TM to extend from residue 55 to 74 
(Figure 3C). We generated constructs with progressively shorter N-terminal soluble domains 
of Sbh1 and tested them in the assay. A complex of ScGet3 with an MBP fusion of Sbh1 
truncated to eight amino acids N-terminal of the TM could be cleaved (Figure 3D, lane 5 
versus 6); however, Sbh1 truncated to three amino acids N-terminal to the TM could not 
(Figure 3D, lane 7 versus 8). Therefore, Get3 sequesters only a few amino acids in addition to 
the hydrophobic TM. This result could also be consistent with the dimer model where the 
groove covers only the TA.
Get3 can form a tetramer in solution
The current model for the function of fungal Get3 is based on Get3 always maintaining a 
dimeric state. ScGet3 purified after expression in E. coli is predominantly a dimer by SEC; 
however, a small pool always purified as a tetramer (Figure 4A & B, solid blue trace). This 
tetramer pool was stable enough to be re-run over the column (Figure 4B, dashed line). We 
noted that the tetramer fraction would degrade over time to dimer, while we would never see 
conversion of the dimer to tetramer. We suspected, as noted below, that the tetramer fraction 
is stabilized by interactions with hydrophobic peptides. In this case, tetrameric ScGet3 might be 
bound to hydrophobic E. coli peptides. We searched for evidence of these by mass 
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spectrometry but were unable to find any E. coli peptides. This may not be surprising, as the 
expected hydrophobic peptides are typically hard to identify by liquid chromatography tandem 
mass spectrometry (Wu and Yates, 2003) and may be in low abundance. 
In contrast to ScGet3, the solution state of MjGet3 is primarily a tetramer by SEC (Figure 4A, 
green trace), which is consistent with the crystal structure. We were interested to see if this was 
a general feature of archaeal Get3 homologues. Get3 from the mesophile M. maripaludis 
(MmGet3) was predominantly tetrameric in solution (Figure 4A, red trace). TkGet3, which 
lacks the coordinating cysteines, is similar to ScGet3 in that the protein elutes as both a 
tetramer and a dimer (Figure 4A, cyan trace).
The interactions forming the tetramer in the MjGet3 crystal structure are primarily 
hydrophobic packing between helix 8 on one subunit and helices 4 and 5 from the opposing 
subunit (Figure 4C). This suggests that the tetramer should be sensitive to detergent. To test 
this, we dialyzed the protein against a 1% (w/v) solution of the small micelle detergent N-
octyl-β-D-glucopyranoside (β-OG) just above the critical micelle concentration. After 
overnight dialysis the majority of the MjGet3 shifted to a peak consistent with a dimer (Figure 
4D, compare green trace to black trace). When we then dialyzed out the detergent, the protein 
returned to the tetramer (Figure 4D, black dashed trace) confirming that in these conditions 
this was the stable state. When we diluted out the detergent in the presence of ATP we saw no 
effect on the oligomeric state, although we did note an increase in absorption consistent with 
nucleotide binding (260/280 ratio went from 0.81 without nucleotide to 1.02 in the presence 
of ATP). This was intriguing, as adding ATP to purified tetrameric MjGet3 would cause the 
protein to precipitate. For further confirmation of the stability and hydrophobic nature of the 
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interaction, we performed SEC of MjGet3 in the presence of high salt (1M NaCl) or 
denaturant (1M urea). Neither affected the oligomeric state (Figure S8).
Helix 8 had been suggested to play an important role in TA-binding, possibly as a cover to the 
groove proposed in the dimer model (Mateja et al., 2009). Deletion of this helix resulted in a 
loss of TA-binding (Yamagata et al., 2010). In the tetramer model, this helix stabilizes the 
interface; therefore, it is critical to formation of the TA-binding hydrophobic chamber. To test 
this directly, we introduced mutations in helix 8 of MjGet3 near the interface of the three-helix 
bundle (Figure 4C). Two of these, F192D and M196D, directly disrupt the hydrophobic 
interface and both of them shift predominantly to a dimer peak by SEC (Figure 4E, red and 
purple trace). A third mutation, M193D, was not at the interface (Figure 4C) and this mutant 
strongly favored the tetramer (Figure 4E, orange trace). Partial deletion of helix 8 resulted in a 
loss of  the tetramer peak as well (Figure 4E, yellow trace).
Fungal Get3 tetramer is capable of  TA membrane insertion in vitro
A biological role for the tetramer complex is difficult to prove directly. We decided to address 
this by demonstrating that our purified Get3/TA tetramer complex was capable of insertion 
into purified yeast microsomes. It had previously been shown that both a fungal Get3/TA 
tetramer complex (Bozkurt et al., 2009) and a mammalian Get3/TA tetramer complex 
(Favaloro et al., 2010) are capable of insertion into mammalian microsomes. In both cases, 
membrane integration was verified by glycosylation of the C-terminus of the TA protein, 
which can only happen if the C-terminus has entered into the lumen of the microsomes. We 
chose to perform a similar assay using all fungal components.
We generated an MBP-tagged Sbh1 with a glycosylation site from opsin at its C-terminus 
(MBP-Sbh1-op). This purified as a stable tetrameric complex with ScGet3. Using this complex 
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we observed successful insertion of MBP-Sbh1-op into S. cerevisiae Δget3 microsomes by 
glycosylation of the C-terminal opsin tag, confirmed by subsequent deglycosylation with the 
endoglycosidase EndoH after disruption of the microsomes (Figure 5A, Lanes 3 & 4). As 
previously seen (Favaloro et al., 2010), no insertion was observed when microsomes were pre-
treated with trypsin (Figure 5A, Lanes 1). Furthermore, insertion is sensitive to the binding of 
nucleotide, here disrupted by the addition of EDTA to the reaction (Figure 5A, Lane 2). MBP-
Sbh1-op could be purified without Get3 and alone failed to insert (Figure 5A, Lane 5). This 
shows that the ScGet3/TA tetramer complex is on a functional insertion pathway. We were 
interested to see if we could get transfer from an archaeal complex into our yeast microsomes. 
We purified a stable MjGet3/MBP-Sbh1-op tetramer complex. This complex was unable to 
insert the yeast substrate into S. cerevisiae Δget3 microsomes (Figure S9A). 
The inability of the archaeal MjGet3/yeast TA tetramer complex to insert into yeast 
microsomes implies that there are significant differences in the putative archaeal pathway at the 
membrane. Indeed, there are no obvious homologues of either Get1 or Get2 in any archaea. 
To further explore the species dependence of our insertion results, we decided to use a 
reconstituted in vitro translation system that has previously been used to demonstrate insertion 
by eukaryotic Get3 variants (Stefanovic and Hegde, 2007). Using lysates from the S. cerevisiae 
Δget3 strain, we were able to reconstitute insertion into purified microsomes using a model 
substrate (N-terminal truncation of MBP-Sbh1-op) dependent on the presence of ScGet3 
(Figure S9B). Based on this, we decided to see if any of the archaeal Get3 homologues could 
facilitate insertion. Similar to the purified complex assay, MjGet3 was unable to facilitate 
insertion, as was MmGet3 or TkGet3 (Figure S9B & C). This suggests that, under these 
conditions, archaeal Get3 homologues are unable to support insertion into fungal microsomes.
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Solution characterization of  Get3 and Get3-TA protein complexes
Complexes between fungal or mammalian Get3 bound to TA-substrates are consistent with a 
tetramer of Get3 (Bozkurt et al., 2009; Favaloro et al., 2010). We decided to assay the 
oligomeric state of various complexes using multi-angle laser light scattering (MALLS), which 
provides a relative molecular weight of the particle. Using this method, both the purified 
ScGet3 dimer and the tetrameric MjGet3 were consistent with calculated molecular weights, 
80.8 kD and 153 kD respectively (Figure 5B and Table 1). Using purified ScGet3/TA 
complexes the experimental molecular weights were consistent with a tetramer of ScGet3; 
however, the stoichiometry of the TA proteins was inconclusive (Figure 5B and Table 1). This 
suggests that more than one TA protein is bound per Get3 tetramer possibly because the 
complex is formed in the absence of other GET partners. The size of the chamber should be 
able to accommodate multiple TA proteins (Figure S5).
The data are consistent with the MjGet3 tetramer having a similar conformation to the Get3/
TA complex. We expected that the elongated dumbbell structure and the stability of the 
purified complexes could be exploited in an analysis using biological small-angle X-ray 
scattering (bioSAXS). The benefit of this technique is that it can provide measures of 
dimensions in solution along with allowing for the calculation of low-resolution molecular 
envelopes (Putnam et al., 2007). bioSAXS curves of MjGet3 and ScGet3/TA complexes show 
similar dimensions such as the radii of gyration (Rg) and maximum dimension (Dmax) (Table 
1). The unbiased overall shapes of the pair-distribution functions, P(r), are also similar with a 
primary peak followed by a shoulder peak (Figure 6A), strongly suggesting a multi-domain 
protein consistent with the crystal structure of MjGet3. This further indicates that the fungal 
and archaeal tetramers have similar overall architectures.
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In addition to overall dimensions, bioSAXS can use the experimentally measured distance 
distributions (Figure 6A) in a variety of refinement procedures to obtain ab initio molecular 
envelopes (Putnam et al., 2007). We used DAMMIN (Svergun, 1999) to calculate molecular 
envelopes of each of our complexes. Knowing that the Get3 tetramer has internal symmetry, 
we imposed P22 symmetry on our model. This did not affect the overall dimensions of any of 
the complexes; however, it was necessary to establish a consistent envelope. We calculated a 
molecular envelope for MjGet3 (Figure 6B). The ab initio fit to the data returned a dumbbell 
shaped envelope consistent with the crystal structure. Viewed down the two-fold along the 
long axis of the tetramer, we measured a crossing angle of the widest point in each of the 
dimers. In the crystal structure this crossing angle is ~30°. Performing a similar measure for 
the molecular envelope results in a crossing angle of ~40°. This suggests that the crystal 
structure stabilizes a slightly twisted form of the MjGet3 compared to the solution state. We 
generated a molecular envelope for both the ScGet3/Ysy6 complex and a truncated ScGet3/
Sbh147-82 complex (Figure 6C & D). These resulted in very similar dumbbell shaped structures 
confirming that the MjGet3 tetramer is a good model for the fungal Get3/TA tetramer 
complex.
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Figures
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Figure 1. The structure of MjGet3. (A) The overall structure of MjGet3 in cartoon 
representation with each subunit colored differently and one subunit color ramped blue to 
red from N- to C-terminus with approximate measurements on the side. Nucleotides are 
represented as sticks and ions as spheres. (B) 90° rotation relative to A. (C) A monomer of 
MjGet3 color ramped as in A overlaid with ScGet3 (2WOJ-A) shown in gray. Helix 1 is not 
resolved in MjGet3 and helix 13 is not obviously present. Dashed line connects helix 8 to 
helix 9. (D) A view of the nucleotide binding pocket highlighting hydrolase features: P-loop 
(cyan), switch I (purple), switch II (blue), and A-loop (orange). The opposing subunit in tan. 
ADP is in sticks colored by atoms. Mg2+ as green sphere. 2F0-FC density for the nucleotide is 
shown as a blue mesh contoured at 2.5σ. (E) A split-view  comparison of the dimers of 
MjGet3 (lavender) and ScGet3 (2WOJ—green). The dimers each have 2-fold symmetry in 
the views shown. For clarity, only half of each structure from the overlay is shown to give a 
direct comparison. MjGet3 on the left and ScGet3 on the right. Colored helices are 4/5 
(teal), 6 (purple) and 7/8/9 (light orange). (F) A 90° rotation relative to E.
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Figure 2. Central cavity. (A) Surface representation of MjGet3 cut through the middle. 
Residues colored based on type: positive charge (blue), negative charge (red) and 
hydrophobic (green). (B) Similar to Figure 1A rotated 90° forward showing the cage walls 
with the foreground removed. (C) External view of the cavity in surface representation 
colored based on electrostatic potential (negative—red to positive—blue). Holes indicated by 
arrow. (D) External view of the central cavity highlighting mutants from previous studies, 
inset shows zoom in region colored similar to Figure 1E. Mutants resulting in a negative 
growth phenotype by (Suloway et al., 2009) are shown in green. Mutants from (Mateja et al., 
2009) are colored according to loss of nucleotide hydrolysis (red), TA-binding (blue) or both 
(purple).
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Figure 3. TA protein binding by Get3. (A) Diagram of recombinantly expressed complex 
showing the two affinity tags used for purification (MBP, maltose binding protein). Position 
of thrombin cleavage site indicated. (B) Coomassie-stained SDS-PAGE of Get3/TA protein 
complexes from various species purified by recombinant co-expression. (C) Sequence of 
Sbh1 fusion to MBP with residues from truncations indicated. The TMD is in bold. (D) 
SDS-PAGE and Western blot of the ScGet3/Sbh1 truncation complexes pre- and post-
thrombin cleavage with αMBP antibody against the MBP-Sbh1 fusion. Accessibility of 
protease site results in a shift of the MBP-Sbh1 fusion to a lower MBP band. Residues 
numbers of  Sbh1 are indicated.
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Figure 4. Oligomeric state of Get3. (A) SEC of Get3 from S. cerevisiae (blue) and three 
archaeal species: M. jannaschii (green), M. maripaludis (red) and T. kodakaraensis (cyan). 
Tetramers and dimers eluted around 12ml and 14ml respectively. (B) SEC run on different 
column of ScGet3 after affinity purification (solid line). The tetramer peak was pooled and 
re-run (dashed line). (C) The three-helix bundle that stabilizes Get3 tetramers colored as in 
Figure 2B with mutated residues highlighted. (D) SEC of MjGet3 in the absence (green) and 
presence (black) of 1% β-OG and a sample where detergent was dialyzed out (dashed). 
Detergent shifts the peak to a volume corresponding to a dimer (13ml). After dialysis the 
peak shifts back to a tetramer (11ml). (E) SEC of MjGet3 mutants. The 192–202 GAAG 
trace (yellow) corresponds to a deletion of  helix 8.
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Figure 5. Functional studies of Get3/TA protein tetramer complex. (A) In vitro 
membrane integration of an MBP fusion to Sbh1 with a C-terminal opsin tag into 
microsomes purified from S. cerevisiae Δget3 by a purified ScGet3/MBP-Sbh1-op complex. A 
Western blot against MBP of in vitro translocation assays into trypsinized yeast microsomes 
(T-YM – Lane 1), in the presence of EDTA (Lane 2), standard in vitro translocation 
conditions before (Lane 3) and after EndoH treatment (Lane 4) and MBP-Sbh1 purified 
without Get3 (Lane 5). Star indicates MBP-Sbh1-op and the arrow  points to band shifted by 
glycosylation of MBP-Sbh1-op after membrane integration. (B) Molecular weights of Get3 
and Get3/TA protein complexes measured by SEC coupled to MALLS. Traces of 
differential index of  refraction (dn/dc) and calculated molecular weights are shown.
124
125
Figure 6. Size and shape of Get3/TA protein complexes. (A) Pair-distribution functions 
from bioSAXS of MjGet3 (blue), ScGet3/Ysy6 and ScGet3/Sbh147-82. (B) Calculated 
envelope of MjGet3 from bioSAXS data (blue mesh) with MjGet3 coordinates fit to the 
overall envelope. Insets are three views 90° rotated around the vertical and horizontal axis. 
Lines are drawn through the widest point of each lobe and a crossing angle is calculated 
along the long axis. Top left inset shows the crossing angle for the structure alone. (C) 
Similar to B for the envelope of ScGet3/Ysy6 complex (green mesh). (D) Same as C for the 
envelope of  the ScGet3/Sbh147-82 complex (salmon mesh).
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Figure 7. Model for Get3 TA protein targeting.
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MALLS ScGet3 MjGet3 ScGet3/
Ysy6
ScGet3/
Sbh1
Get3 Monomer (kDa) 41.3 38.8 40.2 39.4
Get3 Oligomer (kDa) 82.5 155 161 157
Mw measured (kDa) 80.8 153 198 238
Difference (kDa) -2.5 -2.0 +37.1 +80.6
TA Mw (kDa) - - 8.8 9.3
Difference/TA Mw - - 4.2 8.6
SAXS MjGet3
(ADP•AlFx)
ScGet3/
Ysy6
ScGet3/
Sbh1 47-82
Rg theoretical (Å) 44.2 - -
Rg Guinier (Å) 47.0 49.8 52.1
Rg GNOM (Å) 47.5 49.6 51.0
Dmax 165 173 163
Table 1. MALLS and SAXS statistics
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Discussion
The details of the GET pathway are rapidly being discovered. So far, Get3 is the best 
characterized of the components, yet there are still a number of important questions that 
remain to be answered. Here we solve the structure of an archaeal Get3. The structure is a 
tetramer with a hydrophobic chamber that we postulate sequesters TA. We demonstrate that 
archaeal homologues are capable of TA protein binding. Moreover, we show the first 
structural information of fungal Get3/TA protein complexes, which is consistent with the 
biochemical data supporting a tetramer model for TA-binding. 
The presence of a Get3 homologue in archaea is exciting and suggests a novel membrane 
protein-targeting pathway in this domain of life. The lack of homologues of other GET 
components implies that the pathway, if it  exists, will be significantly different. Based on 
structural homology, the fact that archaeal Get3s can bind TA proteins is not surprising; 
however, it supports the possibility of an archaeal TA targeting pathway. It is also interesting 
that an archaeal homologue that does not contain the CxxC motif, TkGet3, is capable of both 
oligomerization and TA binding. This motif is essential in fungal Get3 homologues and may 
suggest an evolutionary path for these proteins. Unlike certain TA proteins (e.g. Secβ  and 
SecE), Get3 homologues are not found universally in archaea. This hints that the presumed 
pathway may not be essential or may be required for specific substrates. The fact that very 
closely related archaea differ in having a Get3 homologue is a question for further study (e.g. 
Pyrococcus abysii versus Pyrococcus furiosus and Pyrococcus horikoshii). 
Tetramers of Get3 have been seen in a variety of contexts suggesting that this state plays a 
functional role in the GET pathway. In the initial functional identification of TRC40 (the 
mammalian homologue of Get3), the protein isolated from in vitro translation in a reticulocyte 
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lysate was seen in a large complex ranging in size compatible with the tetramer (Stefanovic and 
Hegde, 2007). Similarly, the crosslinking of a mammalian Get3/TA complex was consistent 
with tetramers by SDS-PAGE (Favaloro et al., 2008). (Bozkurt et al., 2009) purified a fungal 
Get3/TA protein complex that they determined was a Get3 tetramer by analytical ultra-
centrifugation and SEC. This complex, in an in vitro insertion assay using mammalian ER 
microsomes, is competent for membrane insertion. (Favaloro et al., 2010) completed a similar 
study using a mammalian Get3/TA complex. In this case, the size of the complex was 
compatible with a tetramer by SEC and was also competent for membrane insertion. We have 
now replicated these results in a purified fungal system. Thus, in the cases where functional 
insertion was demonstrated, the oligomeric state of  Get3 is a tetramer. 
It is clear that eukaryotic Get3 can exist as a stable dimer and it is likely this state plays a 
functional role. We, and others, have demonstrated that Get3 is a tetramer when bound to a 
TA substrate and this complex is capable of TA insertion. This conflicts with the dimer model 
suggested based on earlier structures. As we now present a contrasting model, it is useful to 
posit the differences in the two models. The dimer model of Get3 TA binding suggests that 
the HSD captures the length of a TM along a hydrophobic groove with a floor provided by 
helix 6 and helices 4, 5, 7 and 9 providing the walls. In the unbound transition state structure, 
the dimensions of the groove seem compatible with a hydrophobic TM helix; however, while 
covering three sides of the protein the groove leaves one face of the protein exposed to 
solvent. It has been suggested that helix 8 solves this by becoming ordered upon TA binding 
to cover the exposed face. Consistent with this, mutations in the walls of the groove and 
deletion of helix 8 prevent TA binding (Mateja et al., 2009; Yamagata et al., 2010). Similar 
mutations at the bottom of the groove do not significantly affect TA binding; however, they 
clearly play a role in the targeting process (Mateja et al., 2009; Suloway et al., 2009). The dimer 
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model requires that a structured groove accommodate a wide variety of TA substrates along 
with necessitating the binding of an α-helix. This is different from the model for SRP binding 
of a hydrophobic signal sequence, which uses a flexible loop to form its helical binding pocket 
(Bernstein et al., 1989; Keenan et al., 1998). 
The tetramer model resolves a number of the issues that arise in the dimer model. Here, the 
residues in helix 6 that affect nucleotide hydrolysis do not contact the hydrophobic cage 
directly and would not be expected to directly affect TA-binding. Instead, they would relay the 
binding of substrate and oligomerization state to the NHD. Moreover, in a deuterium 
exchange assay the binding of TA leads to exposure of the C-terminus of helix 6, as seen in 
the tetramer; whereas, in the dimer model this should be occluded by TA (Bozkurt et al., 
2009). The binding of a hydrophobic TA stabilizes the tetrameric state of fungal Get3. This 
suggests that energy must be input to destabilize the complex. It also suggests why a Get3 
complex with cytochrome b5, a more hydrophilic TA, does not require energy for insertion as 
it is likely less stable (Stefanovic and Hegde, 2007; Favaloro et al., 2010). It is interesting to 
note that in the conditions tested here the archaeal tetramer is significantly more stable than 
eukaryotic homologues independent of  bound TA.
Both Get3 and ArsA are members of the ‘deviant Walker A motif ’ family of ATPases 
(Koonin, 1993). ArsA is structurally very similar to Get3 (Suloway et al., 2009) and uses ATP 
hydrolysis to facilitate arsenite export (Walmsley, 1999). Binding of arsenite stimulates the 
monomer (effectively a pseudo-dimer) to dimerize (analogous to a Get3 tetramer) (Ching et al., 
1991). Structures of ArsA exist only as monomers, so there appears to be an analogous 
oligomerization in this related system. It would be interesting to see if the solution structure of 
ArsA bound to arsenite is compatible with the tetramer described here. Other members of 
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this ATPase family that have been characterized are soluble dimers that also form higher order 
functional complexes either as homo-oligomers (e.g., Soj; (Leonard et al., 2005) and MinD; 
(Hayashi et al., 2001)) or as hetero-oligomers (e.g., NifH; (Schindelin et al., 1997)); therefore, a 
role of  higher order oligomerization may be a general feature of  this family.
A remaining complication in this study is the stoichiometry of the tetramer/TA complex. The 
current idea is that a single TA protein binds to the Get3 complex. While this is attractive, 
there is no biochemical data that supports this; indeed it is difficult to prove. It is clear that our 
tetramer complex contains minimally a single TA protein; however, the biophysical data 
suggests that there are more copies bound. The size of the chamber easily accommodates a 
single TM with ample space for additional TMs. Moreover, the hydrophobic nature of 
tetramer formation presumably allows for flexibility of the chamber that may expand to bind 
more substrates. A recent study by (Leznicki et al., 2011) used chemical modification to the 
TM of the TA to explore the flexibility of the TA binding pocket. Addition of a single large 
polyethylene glycol (PEG) adduct to the TM did not inhibit binding or insertion; however, 
modification at two sites prevented binding independent of whether the attachments were on 
the same or opposite sides of a presumed helix. The single site addition is clearly compatible 
with a dimer model; however, it is inconsistent with a second binding site on the same side not 
binding. The tetramer model is also consistent with a single site modification as the two 
proposed chamber access points could accommodate both protein or extended PEG. A 
second site would have a harder time being accommodated and would presumably reduce the 
affinity. Overall, these results point to surprising flexibility in binding to Get3.
The role of nucleotide in TA-targeting remains to be determined. All of the current evidence 
demonstrates that nucleotide hydrolysis is required at the membrane but not for TA-binding 
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(Stefanovic and Hegde, 2007; Favaloro et al., 2008; 2010). Mutants deficient in nucleotide 
binding efficiently bind to TA-substrate in both in vitro (Stefanovic and Hegde, 2007) and 
heterologous expression assays (Yamagata et al., 2010). Structural studies suggest that Get3 
undergoes distinct conformational changes from an ‘open’ to ‘closed’ form that is stimulated 
by the nucleotide state. The closed form of Get3 has only been seen in the presence of 
nucleotide, independent of the γ-phosphate (Mateja et al., 2009; Bozkurt et al., 2009). The 
open form has been seen in both the apo and ADP complex (Mateja et al., 2009; Suloway et 
al., 2009; Yamagata et al., 2010). This suggests that there is conformational flexibility with 
bound nucleotide favoring the ‘closed’ state (Chartron et al., 2010). Neither our purified 
MjGet3 nor our ScGet3/TA complex contain bound nucleotide consistent to what has been 
seen before (Bozkurt et al., 2009; Favaloro et al., 2010). Purified Get3/TA complexes require 
nucleotide to stimulate insertion implying that the nucleotide-binding pocket (NBP) is solvent 
accessible (Bozkurt et al., 2009; Favaloro et al., 2010). With a bound transition state analog the 
NBP is closed to solvent (Mateja et al., 2009); however, in the closed form bound to ADP the 
switch II loop has moved, exposing the NBP (Bozkurt et al., 2009). This conformation 
cannot hydrolyze ATP and is similar to the position of switch II in our MjGet3 tetramer. 
Therefore, in the Get3 tetramer the NBP is more accessible allowing diffusion in or out of 
nucleotide. The high cellular concentration of ATP makes it likely that this is the bound form. 
Disruption of the tetramer would be required for switch II to occupy a hydrolysis competent 
conformation. This disruption would result in substrate release and may be facilitated by 
factors at the membrane.
In the fungal GET pathway each of the soluble proteins exists minimally as dimers. Sgt2, the 
first protein in the pathway to specifically bind the TA (Tobaben et al., 2003; Wang et al., 
2010), is a homodimer with an N-terminal dimerization domain (Liou and Wang, 2005). Get4 
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and Get5, which link Sgt2 to Get3, are hetero-tetramers with a C-terminal dimerization 
domain in Get5 (Chartron et al., 2010). This all suggests a larger functional complex in TA 
protein recognition and delivery (Chartron et al., 2011). The ability of Get4, minimally present 
in two copies, to bind directly to a dimer of Get3 is consistent with the possible specific 
recognition of  a tetramer or two dimers. 
All of this allows us to suggest a modified model for Get3 mediated targeting of a TA protein 
(Figure 7). (1) Get3 in its apo form is a stable and soluble dimer in equilibrium between an 
‘open’ and ‘closed’ form. (2) Binding of nucleotide shifts the equilibrium towards the ‘closed’ 
form that is compatible with binding Get4. This is now competent for TA binding. (3) Binding 
of the TA results in tetramer formation. Conformational changes to form the tetramer cause 
release from Get4 and diffusion of the Get3/TA complex to the membrane. (4) Here, the 
receptor complex stimulates release of TA and insertion into the membrane. Get3 now 
returns to the dimer state to bind new TA substrates.
A related structural study on archaeal Get3 was published while this manuscript was in review. 
Their crystal structure of Get3 from the archaea Methanothermobacter thermautotrophicus (MtGet3) 
is consistent with the results presented here in that the archaeal homologue is structurally 
similar to fungal counterparts (Sherrill et al., 2011). In this case, a dimer was specifically 
purified and crystallized; therefore, they do not investigate the tetramer that we report. 
Interestingly, the loops that extend to form our tetramer are also extended in the dimer of 
MtGet3 perhaps explaining why the archaeal tetramer is more stable. Excitingly, there they 
were able to demonstrate that MtGet3 can facilitate TA insertion using a protease protection 
assay. This difference from our result might be assay specific or could be related to the species 
of  Get3 and TA protein tested.
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Also while this manuscript was in review, two reports on the interaction of Get3 with the 
membrane proteins Get1 and Get2 were published (Mariappan et al., 2011; Stefer et al., 2011). 
In both studies, structures of Get3 dimers are bound to the soluble domains of either Get1 or 
Get2. The structures suggest how Get1 and Get2 can recognize Get3 and facilitate release of a 
TA protein. These structures do not contain TA proteins. We believe the evidence is 
compatible with a model in which a tetrameric Get3/TA protein complex is captured by Get2 
then disrupted by Get1 to release the TA protein for insertion.
Get3 is a dynamic protein that undergoes a complex series of conformational changes in 
delivery of a TA protein to the ER. Here we present the first structural information of Get3/
TA complex from a heterologously expressed system demonstrating that Get3 in this state is a 
tetramer. The tetramer model suggests a TA is sequestered within a hydrophobic chamber. 
Further studies are required to establish the role of the tetramer in vivo. An unresolved point 
is the stoichiometry of the TA proteins to Get3, which probably requires other GET 
components to determine. Finally, the functional role of the Get3 archaeal homologue is a 
tantalizing question, particularly with the broader context of the detailed molecular mechanism 
of  TA protein targeting by the GET pathway.
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Materials and Methods
Cloning, expression and purification
All Get3 homologues were amplified from genomic DNA and cloned into a pET33b vector 
(Novagen) modified to contain only an N-terminal 6×His tag. Genomic DNA for MjGet3 
(MJ_1142) from M. jannaschii DSM 2661 (ATCC), TkGet3 (TK_0994) from T. kodakaraensis 
KW128 (Santangelo et al., 2007), MmGet3 (MmarC7_1163) from M. maripaludis C7 (ATCC), 
and ScGet3 from a previous study (Suloway et al., 2009). For MjGet3, site-directed 
mutagenesis was used to generate a truncation encoding amino acids 12–349 of MjGet3 
(MjGet312–349) and 12–333 of MjGet3 (MjGet312–333). For co-expression, MjGet312-349, 
TkGet3 and ScGet3 were cloned into the first multiple-cloning site (MCS) of pACYCDuet 
(Novagen). TA proteins (Ysy6 YBR162W-A, Sbh1 YER087C-B, Secβ (Kinch et al., 2002; Van 
Den Berg et al., 2004), SecE MJ_0371, MtrA MJ_0851, MtrB MJ_0850) were amplified from 
genomic DNA and cloned into pMAL-C2 (NEB) modified to contain a thrombin site 
between MBP and the MCS. Truncations of Sbh1 were generated by site-directed mutagenesis. 
Gene annotations are from KEGG (http://www.genome.jp/kegg/).
Get3 homologues were expressed in BL21-Gold(DE3) (Stratagene) in 2×YT at 37°C for 3h 
(induced at A600=0.6 with 0.3mM isopropyl-β-D-thiogalactoside). Cells were pelleted, 
resuspended in Buffer A (50mM Tris pH 7.5, 300mM NaCl, 10mM β-mercaptoethanol 
(βME)) with protease inhibitors, and lysed through a ML-110 microfluidizer (Microfluidics). 
Lysate was centrifuged and supernatant was passed over Ni-NTA resin (Qiagen), washed with 
Buffer A with 10mM imidazole and eluted in Buffer A with 200mM imidazole. The eluate was 
incubated with 2U thrombin per ml (Sigma) at room temperature (RT) while dialyzing against 
Buffer A for 16h. The reaction was stopped with 1mM PMSF and passed over Ni-NTA resin 
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to remove uncleaved product and contaminants. Flow-through was purified on a Superdex 200 
column (GE Healthcare) (10mM Tris pH 7.5, 100mM NaCl, 10mM βME). Selenomethione 
derivatives were expressed by auto-induction media and purified the same method as native 
(Studier, 2005). ScGet3 tetramers were analyzed for extraneous peptides by tryptic digest 
followed by LC/MS at the Caltech Protein/Peptide MicroAnalytical Laboratory.
Crystallization
MjGet312-349 crystallized in the P21 form in 2 days at RT by sitting-drop vapor diffusion by 
mixing 1μl of 10mg/ml MjGet3 (10mM Tris pH 7.5, 100mM NaCl, 10mM βME, 2mM 
MgCl2, 2mM ADP, 0.5mM AlCl3, 8mM NaF) with 1μl of reservoir solution (0.1M Na2SO4 
and 9% (w/v) PEG 3350). Crystals were cryo-protected with artificial mother liquor 
containing 20% glycerol or 17.5% sucrose and 17.5% xylitol before flash freezing in liquid N2. 
Seleno-methione crystals were obtained in the same way. MjGet312-333 crystallized in the P2 
form after 1 day in drops of 1μl of 10mg/ml MjGet3 (10mM Tris pH 7.5, 100mM NaCl, 
10mM βME, 2mM MgCl2, 2mM ADP) and 1μl 0.2M Na2SO4 and 10% (w/v) PEG 3350 and 
cryoprotected with 20% ethylene glycol.
Data collection, structure solution and refinement
All native data collection was done at SSRL BL12-2 at a wavelength of 1.000Å at 100K. 
Selenomethionine derivative data were collected at the APS GM/CA-CAT BL23ID-D at a 
wavelength of 0.9795Å at 100K. Diffraction data were integrated with iMosflm (Leslie, 1992) 
and scaled with CCP4/Scala for P21 data (CCP4, 1994) and XDS for P2 data (Kabsch, 2010). 
Molecular replacement (MR) with native P21 data was performed with CCP4/Phaser (McCoy, 
2007) with a NHD from 3IBG. MR for native P2 data was by phenix.automr used a starting 
model of a NHD monomer from MjGet3 P21. The P21 form consisted of a single MjGet3 
137
tetramer in the asymmetric unit. The P2 form contained four monomers assembled in two 
crystallographic tetramers aligned along the long axis of symmetry. Rounds of model building 
and refinement were done with Coot (Emsley and Cowtan, 2004) and phenix.refine (Adams et 
al., 2002). Global non-crystallographic symmetry (NCS) was used in the P21 refinement with 
weights calculated in phenix.refine. Residues that we were not able to resolve in both crystal 
forms varied between subunits but included the N-terminus (2-23/25), the loop between 
helices 8 and 9 (202-209) and the C-terminus (333/334-349). In P2, we could see density in 
chain A that is consistent with helix 1 of chain A in P21 but were unable to build into it with 
confidence. Additionally, we were unable to convincingly model density in the nucleotide-
binding pocket near the magnesium and aluminum fluoride-binding site. As we see it in both 
forms it could be a sulfate ion; however, we do not have direct evidence for this. TLS 
(translation/libration/screw) vibrational motions were calculated using the TLSMD server 
(Painter and Merritt, 2006a; 2006b) and used in the refinement. After initial modeling and 
refinement the P2 model then refined against data corrected by the Diffraction Anisotropy 
Server (Strong et al., 2006) limiting the resolution in directions a* to 3.3Å, b* to 2.9Å and c* 
to 3.4Å. The final P21 model had an Rwork of 25.1% and an Rfree of 28.6% with residues in the 
Ramachandran plot in 97.5% preferred, 2.5% allowed and 0.0% in the disallowed and 
restricted regions. The final P2 model had an Rwork of 27.0% and an Rfree of 29.6% with 
residues in the Ramachandran plot in 96.2% preferred, 3.8% allowed and 0.0% in the 
disallowed and restricted regions. Ramachandran statistics are taken from PHENIX. All 
structure figures were made using PyMOL (Schrödinger, LLC) except for 2a, 5, and S5 which 
were made using UCSF Chimera (Pettersen et al., 2004).
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Pull-downs
ScGet3, MjGet3 or TkGet3 and TA proteins were co-expressed in BL21-Gold(DE3) E. coli. 
Soluble complexes were purified in two steps using amylose resin (NEB) and Ni-NTA resin. 
ScGet3 complexes with Sbh1-truncations were purified by the same method followed by 
incubation with 2 U of  thrombin per ml at room temperature overnight.
Microsome insertion assay
The ScGet3 complex with MBP-Sbh1-op was co-expressed and purified as for the pull-downs 
followed by SEC on a Superdex 200 10/300. MBP-Sbh1-op was purified using amylose resin. 
Microsomes from WT and Δget3 strains were prepared as in (Schuldiner et al., 2008). Purified 
complex or MBP-Sbh1-op and Δget3 microsomes were used for the insertion assay using the 
conditions reported in (Bozkurt et al., 2009).
S. cerevisiae translation extracts were prepared essentially as in (Wu et al., 2007), and included 
an additional centrifugation step at 49,000 rpm in an Sw55Ti for 30 minutes after the low 
speed centrifugation step (following cell lysis). In vitro translations were carried out as in (Wu 
et al., 2007). Translation reactions were performed with Δget3 extracts in a 10 μL scale with 
10μCi [35S] methionine in the presence of recombinant Get3 (concentrations indicated on 
gel). To assay post-translational TA protein insertion, the following was added after 30 
minutes: 1 mM cycloheximide, 1 μL energy mix (8.3 mM ATP, 1,7 mM GTP, 200 mM creatine 
phosphate, 600 mM KOAc, 10 mM MgOAC), and 0.006 U/uL YRMs (WT or Δget3). 
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SEC-MALLS
Purified proteins were run on a Shodex KW-804 column (10mM Tris pH 7.5, 100mM NaCl, 
10mM βME) with MALLS data collected on a DAWN HELEOS and Optilab rEX detector 
(Wyatt). Data were processed using ASTRA (Wyatt) software.
SAXS
Purified MjGet312-349 and ScGet3 complexes with TA-substrates were dialysed against 20mM 
Tris pH 7.5, 250mM NaCl and 10mM βME. MjGet312-349 samples were also prepared by 
dialysis against the same buffer containing 2mM MgCl2, 2mM ADP, 8mM NaF, 0.5mM AlCl3 
and 1mM ZnSO4. Solution small-angle X-ray scattering (SAXS) experiments were done at 
SSRL BL4-2 at RT. SAXS diffraction images were processed using SASTool and PRIMUS 
(Konarev et al., 2003), data were analyzed with PRIMUS/autorg/autoporod, particle distance 
functions were generated with GNOM/autognom (Svergun, 1992) and ab initio shape 
determination was done with DAMMIN (Svergun, 1999).
ICP-MS measurement
The zinc and magnesium occupancy was quantified by ICP-MS similar to (Yamagata et al., 
2010). Samples were measured using a HP-4500 ICP-MS (Agilent Technologies). The 
concentration of the Get3/TA complex was measured at between 3.24 and 3.48 μM 
assuming a Get3 tetramer bound to either one or four substrates. The zinc concentration was 
measured at 5.66 μM consistent with two ions per tetramer. The magnesium concentration 
was measured at 1.9 μM indicating less than one ion per tetramer, consistent with no 
detectable amount of  magnesium binding, which is required for nucleotide binding.
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Supplementary Figure 1. Sequence alignment of Get3 Sequences were aligned with 
ClustalX (http://www.clustal.org). M. jannaschii (Mjann), M. maripaludis C7 (Mmar7), 
Haloferax volcanii arsA1 (Hvol1), Homo sapiens (Hsapi), S. cerevisiae (Scere), H. volcanii arsA2 
(Hvol2), T. kodakaraensis (Tkoda), the N- and C-terminal sequence of E. coli Arsa (1F48N 
and C). Amino acids are colored according to conservation and type from ClustalX output. 
Features are labeled and colored according to Figure 1D, helices are numbered and 
secondary structure is colored as in Figure 1E. Sequence numbering is for MjGet3. 
Truncated residues for MjGet3 construct highlighted in red and disordered polypeptide in 
gray. Mutants tested are marked by triangles colored as in Figure 5B.
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Supplementary Figure 2. Asymmetric units of the two MjGet3 crystal forms. (A) 
MjGet3 P21 crystal form colored as in Figure 1A. (B) As in (A) for the P2 
crystal form. Note that the tetramer is formed on a crystallographic axis. (C) 
Crystal packing of the MjGet3 P21 crystal form (green). (D) As in (C) for the 
P2 crystal form (blue).
146
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Supplementary Figure 3. Comparison of Get3 structures. A sampling of existing Get3 
structures are compared. Each structure has been aligned to the lavender MjGet3 monomer. 
The first column lists the PDBID, publication, species, nucleotide and open or closed state 
associated with the structure. The next two columns show  a view as in Figure 1E and a view 
as in Figure 2B each colored as in Figure 1E. The last column shows the nucleotide 
hydrolase domain colored as in Figure 1D with all structures aligned to the P-loop.
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Supplementary Figure 4. MjGet3 switch II and electron density. (A) The MjGet3 switch 
II  loop shown in stick representation colored as in Figure 1D with electron density 
contoured at 1.5σ  (blue mesh). (B) A cartoon representation comparison of the MjGet3 
switch II loop to that of ScGet3 (2WOJ). Both structures are colored as in Figure 1D except 
2WOJ has been lightened. (C) A representative view  of an anomalous difference map 
calculated for the Se-met dataset (contoured at 2.8σ, orange mesh) to ensure registry for the 
cage (methionines are labeled).
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Supplementary Figure 5. Secβ  fits inside the tetramer cavity.  (A) Cartoon 
representation of Secβ  from 1RH5 (magenta) aligned along the long axis inside the 
tetrameric MjGet3 cavity similar to Figure 2A. General dimensions are noted (B). Second 
view  of the cavity rotated 90° from (A) with Secβ  rotated to be orthogonal to the long axis. 
(C) Same orientation as (B) in cartoon representation.
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Supplementary Figure 6. Get3 mutational analysis. Three additional views of Figure 2D. 
Colors and mutants listed for ScGet3 followed by the equivalent MjGet3 residue in 
parenthesis. (A) Full view with the same orientation as Figure 1A. (B) Rotated approximately 
90° from (A) viewed along the putative groove. (C) Inside the cage looking towards a dimer 
(same orientation as Figure 2B).
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Supplementary Figure 7. Controls for the purification of complex from various 
species. (A) SDS-PAGE visualized with Coomassie staining demonstrating the two-step 
affinity purification of the complex of MjGet3 and MBP-Sbh1 and MjGet3 and MBP-Sbh1 
without the TM of Sbh1 (Sbh1 ΔTMD). Lanes 1 & 4 are the flow  through for the amylose 
affinity step containing impurities and uncomplexed Get3. Lanes 2 & 5 are the flow  through 
for the Ni affinity step using the elution from the amylose column containing uncomplexed 
MBP-Sbh1. Lanes 3 & 6 contain the elution from Ni affinity column with either bands for 
the MBP-SBh1 and Get3 eluted as a complex for the full length Sbh1 or no bands for the 
absence of a complex for Sbh1 ΔTMD. (B) A Western blot against the MBP tag on the 
MBP fusions to various TA proteins when complexed to MjGet3 and TkGet3 as shown in 
Figure 3B with the addition of  Sbh1 ΔTMD.
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Supplementary Figure 8. SEC of MjGet3 in high salt and denaturant. Size-exclusion 
chromatogram of MjGet3 run in a control buffer of 0.1M NaCl (green), high salt 1M NaCl 
buffer (blue) and a buffer contain 1M urea as a denturant (red).
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Supplementary Figure 9. Membrane insertion assays.  (A) Membrane insertion assay of 
MBP-Sbh1-op by purified MjGet3/MBP-Sbh1-op and ScGet3/MBP-Sbh1 as in Figure 5A 
Lanes 1–4. In vitro translation of a N-terminally truncated MBP-Sbh1-op in the presence of 
(B) ScGet3 or MjGet3 into ΔGet3 S. cerevisiae microsomes or (C) in the presence of MmGet3 
or TkGet3 into wild-type S. cerevisiae microsomes analyzed by SDS-PAGE followed by 
autoradiography.
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Supplementary Figure 10. bioSAXS data analysis. Experimental scattering curves (blue) 
and the fit from best single calculated envelope (green) for (A) MjGet3, (B) ScGet3/Ysy6 
complex and (C) ScGet3/Sbh147-82 complex.
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MjGet3 P2 MjGet3 P21 MjGet3 P21 Se-Met
Data collection
Space group P2 P21 P21
Cell dimensions
    a, b, c (Å) 71.95, 149.64, 72.89 85.74, 76.87, 127.81 86.71, 76.54, 128.12
    α, β, γ (°) 90.00, 94.24, 90.00 90.00, 108.83, 90.00 90.00, 108.82, 90.00
Resolution (Å) 37.41-3.19 (3.36-3.19)* 50.00-3.30 (3.48-3.30)* 50.00-3.80 (4.01-3.80)
Rmerge 9.5 (69.0) 15.1 (71.2) 26.4 (70.4)
I / σI 8.5 (1.3) 6.3 (2.1) 8.3 (3.4)
Completeness (%) 95.3 (92.1) 96.2 (95.0) 99.9 (100.0)
Redundancy 2.9 (2.8) 3.1 (2.9) 8.6 (8.7)
Refinement
Resolution (Å) 37.4-3.2 42.9-3.3
No. reflections 46,076 22,946
Rwork / Rfree 25.0/29.6 24.2/28.2
No. atoms 9,906 9,754
    Protein 9,790 9,640
    Ligand/ion 116 114
    Water 0 0
B-factors 107.7 81.9
    Protein 107.9 82.2
    Ligand/ion 89.3 56.5
    Water - -
R.m.s. deviations
    Bond lengths (Å) 0.018 0.029
    Bond angles (°) 1.60 1.70
Values in parentheses are for highest-resolution shell.
Supplementary Table 1. Data collection and refinement statistics
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CONCLUSION
In the five years following the discovery of Get3 as a TA protein translocation factor 
(Stefanovic and Hegde, 2007; Favaloro et al., 2008) there have been rapid advances in our 
knowledge about how TA proteins are targeted to the ER membrane. The elucidation of the 
pathway in S. cerevisiae lead to the discovery of the membrane receptor Get1/2 (Schuldiner et 
al., 2008) and upstream factors Get4/5 (Jonikas et al., 2009) putting Get3 in a larger context as 
part of  a group of  proteins that form a TA protein translocation pathway.
Structural studies of Get3 demonstrated how an open form of homodimeric Get3 would bind 
ATP to form a closed form presenting a binding pocket for TA proteins (Hu et al., 2009; 
Mateja et al., 2009; Suloway et al., 2009; Bozkurt et al., 2009; Yamagata et al., 2010). This was 
followed by studies showing the structure of Get4 with the N-terminal domain of Get5 forms 
a binding surface for Get3 and that a dimer of Get5 binds monomers of Get4 at each end to 
form a heterotetramer (Bozkurt et al., 2010; Chang et al., 2010; Chartron et al., 2010).
Sgt2 was identified as another component of the GET pathway through interactions with 
Get4/5 (Copic et al., 2009; Chang et al., 2010; Costanzo et al., 2010). Get4/5 was shown to 
mediate the loading of TA proteins from Sgt2 to Get3 (Wang et al., 2010). The TA protein 
loading complex in mammals was discovered to be SGTA and BAG6/TRC35/UBL4A 
analogous to Sgt2 and Get4/5, respectively (Leznicki et al., 2010; Mariappan et al., 2010). The 
mammalian homolog of Get1 was identified as WRB and shown to mediate TA protein 
insertion into membranes (Schuldiner et al., 2008; Vilardi et al., 2011). Archaeal homologs of 
Get3 were found bioinformatically (Borgese and Righi, 2010) and shown to be structurally 
similar as well as capable of binding and integrating TA proteins into the membrane (Sherrill 
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et al., 2011; Suloway et al., 2012). This expanded the scope of Get3 from specifically targeting 
TA proteins to the ER in eukaryotes to include prokaryotic TA protein translocation.
Structures of Get3 complexed with either the soluble domains of Get1 or Get2 along with 
biochemical evidence has formed the basis for a model for membrane insertion (Mariappan et 
al., 2011; Stefer et al., 2011). In this model Get2 tethers Get3 complexed with TA protein to 
the membrane followed by Get1 displacing Get2 and stimulating the release of TA proteins 
for membrane integration. The larger picture of the structure and function of the sorting 
complex of Get4/5/Sgt2 along with chaperones has been elucidated by biochemical studies 
and structures of Sgt2 and the Get5 dimerization domain (Chartron et al., 2011; 2012). 
Structural evidence from SAXS and biochemistry have elaborated on the nature of the 
interaction of  Get3 with Get4/5 (Chang et al., 2012).
This work has presented a model for TA protein targeting by Get3. The structure of Get3 
from Aspergillus fumigatus complexed with ADP shows a that dimer of Get3 formed by 
interactions between the nucleotide hydrolase domains has a similar architecture to members 
of the SIMIBI class nucleotide hydrolyases NifH and ArsA. Helices that extend out from the 
NHD contain conserved hydrophobic residues make a plausible site for TA protein binding. 
By modeling a rotation between the two domains based on the conformational changes 
between the open and closed form of NifH the dimer interface is brought together along with 
the putative TA protein binding site. Using a phenotypic rescue assay, the importance of 
residues at the dimer interface and hydrophobic residues for possible TA protein binding was 
demonstrated. A model was posited where an open form of Get3 in apo or ADP bound state 
was transformed into a closed form competent for TA protein binding when ATP was bound, 
and the TA protein would be released after nucleotide hydrolysis.
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A recombinant co-expression system was developed for obtaining a variety of complexes of 
Get3 with TA proteins for structural studies. Purification by two-step affinity chromatography 
yielded purified complexes that by SEC showed a higher oligomeric state for Get3 when 
complexed with TA proteins. Crystals from purified complexes failed to diffract X-rays to 
sufficient resolution for structural studies. To form complexes with different nucleotide states, 
an in vitro reconstitution system was developed where solubilized TA proteins were added to 
Get3 incubated with nucleotide and nucleotide state analogs. Quantities of complex necessary 
for structural studies have yet to be obtained.
The structure of an archaeal homolog of Get3 from M. jannaschii revealed the same basic 
structural features as fungal Get3. Archaeal Get3 can bind fungal and archaeal TA proteins to 
form stable complexes indicating its role in TA protein translocation. The MjGet3 structure is 
a tetramer formed by two Get3 dimers interacting between the putative TA protein binding 
helices extending out from the NHD. The solution state of MjGet3 and other archaeal Get3 
homologs is also tetrameric and can be disrupted by detergent or mutations to the 
tetramerization interface seen in the structure. Strikingly, at the center of the MjGet3 tetramer 
is a hydrophobic chamber that accommodates the size and biochemical properties of a TA. 
Get3 sequesters only the TA as shown by a specific protease protection assay. Fungal Get3 
complexed with TA proteins is tetrameric in solution and the idea that Get3 binds a TA 
protein as a tetramer in a central hydrophobic chamber reconciles previous mutagenesis 
experiments. Recombinantly co-expressed tetrameric Get3-TA protein complexes are 
functional, capable of integrating TA proteins into the membrane using in vitro translocation 
assays. Finally, SAXS shows the shape of tetrameric MjGet3 and Get3-TA protein complexes 
in solution are very similar and fit the crystal structure of MjGet3. This evidence leads to a 
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model where tetrameric Get3 sequesters TA proteins in a central hydrophobic chamber, in 
contrast to previous dimeric binding models.
In recent times our understanding of the GET pathway has developed significantly and given 
insight into the overall process of integral membrane protein translocation, but there is still 
much to be explored. The architecture and dynamics of the sorting complexes in yeast and 
mammals and how TA proteins destine for different locations are differentiated continues to 
be elucidated. Their are still questions about the exact nature of the nucleotide hydrolysis cycle 
and how it regulates the interaction of Get3 with the sorting complex, TA proteins and the 
membrane receptor. Models for the molecular interactions of Get3 with TA protein await 
more structural and in vivo studies. The role of the GET pathway and TA protein 
translocation outside of eukaryotic organisms is a new frontier for study. Future studies of the 
GET pathway will serve to increase our understanding of the fundamental process of protein 
translocation.
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